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The purpose of this introduction is to inform the reader on Bovine Viral Diarrhoea 
(BVD). Only selected topics, of relevance for this thesis, have been included. First, the 
Bovine Viral Diarrhoea Viruses (BVDV) are introduced, followed by sections dealing with 
pathogenesis, prevalence, clinical features, economic consequences, diagnosis, and control of 
BVD in cattle. 
 
The viruses 
BVDV are single stranded RNA viruses belonging to the Pestivirus genus, within the 
Flaviviridae family. The Pestivirus genus currently comprises four recognized species: 
Border Disease Virus (BDV), Classical Swine Fever Virus, BVDV1, and BVDV2. 
Furthermore, there are four proposed “atypical” species of pestiviruses: Giraffe, HoBi, 
Pronghorn Antelope, and Bungowannah (Schirrmeier et al., 2004; Kirkland et al., 2007; 
Ridpath and Fulton, 2009; Booth et al., 2013a).  
Through high rates of point mutations and recombinations, RNA viruses are constantly 
changing (Kümmerer et al., 2000; Becher et al., 2001). Hence, BVDV is not one virus, but a 
group of many genetic variants. Both BVDV1 and BVDV2 species (types) are divided into 
several genetic subspecies (subtypes), as indicated by lowercase following the species 
number, for example “BVDV1b” (Fig. 1). Most subspecies comprise different strains (Vilcek 
et al, 2005). Occasionally, a strain can change to a more virulent strain. This might explain 
the periodic emergence of acute outbreaks of disease (Bolin and Grooms, 2004). 
Nevertheless, in general, BVDV strains remain stable within herds during the course of an 
infection (Vilcek et al., 1999; Booth et al. 2013). In the USA up to 40 % of the genotyped 
BVDV strains belong to the BVDV2 species (Fulton et al., 2000b), whilst in Europe the 
fraction of BVD2 diagnosed in laboratories is lower than 7% in all countries (Ridpath, 2010a; 
Letellier et al., 2010). Rare outbreaks associated with BVDV2 have been described in 
Europe. An outbreak caused by a bovine herpesvirus 1 marker vaccine contaminated with 
BVDV2 took place on Dutch dairy farms in 1999 (Barkema et al., 2001). In January 2013, 
outbreaks of severe disease associated with BVDV2 occurred in some German and Dutch 
veal calf herds (Doll and Holsteg, 2013; Moen, 2013). High fever, haemorrhagic disease and 
pneumonia were the predominant clinical signs.  
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Figure 1. The pestivirus species, BVDV included: species (types) BVDV1 and BVDV2 with 
their subspecies (subtypes). Source: Peterhans et al., 2010. The branch lengths of the 
phylogenetic tree are proportional to the genetic distances between strains.  
 
Besides the genetic division, BVDV can also be classified according to their biotype. 
Viruses of all strains belonging to both genotypes may exist as two different biotypes, namely 
cytopathic (cp) and non-cytopathic (ncp) (Peterhans et al., 2010). This distinction is 
determined by the ability of the virus to cause cytopathic effect in permissive cell cultures, 
but, more importantly, the difference between the two biotypes plays a role in the 
pathogenesis of BVD. Ncp BVD viruses predominate in the field. Because cp viruses are 
“pop up and disappear” viruses (Peterhans et al., 2010), they are rare and usually only found 
in association with outbreaks of Mucosal Disease (MD) (Ridpath, 2005; Ridpath, 2010a). 
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Pathogenesis 
Transient infection  
In cattle BVD is a systemic disease. The most frequent route of natural infection is by 
oro-nasal uptake of BVDV. The tonsils are the primary replication site. From there the 
BVDV spreads to the lymphocytes in the local lymph nodes and from there to several organs 
and tissues via infected lymphocytes in the blood circulation. After oro-nasal infection of 
cattle, the virus first replicates in the tonsils. From there it spreads to the regional lymph 
nodes via infected lymphocytes. Afterwards, for low virulent strains the infection remains 
limited to lymphoid tissues, but through viraemia more virulent genotypes are able to infect 
more organs and tissues, from the epithelium of the digestive tract to the lungs, urinary tract, 
heart and skin (Bruschke et al., 1998; Liebler-Tenorio, 2005). The pregnant uterus, placenta, 
and foetus easily become infected (Frederiksen et al. 1999), even when the dam is 
subclinically infected (Liebler-Tenorio, 2005). When susceptible, immunocompetent cattle 
become infected with a virulent BVDV strain, the outcome may be severe disease with 
mortality. However, in most of the cases the infection will pass with only mild disease or 
remain asymptomatic (Baker, 1995), but all infected cattle undergo momentary 
immunosuppression (Wilhelmsen et al., 1990; Walz et al., 1999; Brackenbury et al., 2003; 
Ridpath, 2010b; Chase, 2013). In general, about 10 days after infection, the immune system 
of Transiently Infected (TI) cattle succeeds in removing the virus from the blood and from 
that moment on, antibodies begin to appear in the blood (Müller-Doblies et al., 2004; 
Sarrazin et al., 2013b). The animal remains seropositive for BVDV during its entire life 
(Brownlie, 1990), “entire life span” in this case meaning the normal life span of commercial 
cattle. It is worth mentioning that this lifelong seropositivity does not necessarily result in 
lifelong protection against re-infection (Lindberg et al., 2008).  
Because of the short duration of the infection and the intermittent shedding of relatively 
low amounts of virus, TI animals are believed to be of minor importance in the epidemiology 
of BVD. Some studies demonstrated no spread of BVDV by experimentally infected animals 
(Niskanen et al., 2000; Niskanen et al., 2002). Recent results of Sarrazin et al. (2013b) 
confirm these observations, since only very limited virus transmission was demonstrated 
when calves were experimentally infected with a virulent BVDV1 or BVDV2 strain. 
Although they are not of major importance epidemiologically, TI cattle contribute towards 
the majority of any observed production losses in infected herds.  
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Persistent infection 
The main impact of BVDV on cattle health is caused by intrauterine infections. Infection 
of the foetus can cause early embryonic death, congenital malformations, and birth of 
persistently infected calves. When a dam, and consequently her foetus, becomes infected with 
ncp BVDV between 30 and 125 days of pregnancy (Blanchard et al., 2010), the foetus will 
accept the virus as belonging to its own organism, since it is not immunocompetent at that 
stage. As a result the calf becomes lifelong infected and will be persistently shedding the 
virus (Brownlie, 1990).  
These Persistently Infected (PI) cattle play the principal role in spreading the infection, as 
they persistently shed massive amounts of ncp BVDV through all their secretions and 
excretions. Hence, the sources of new BVDV infections are almost always PI (Lindberg and 
Houe, 2005). Iatrogenic transmission by persons, vaccines, calf sera, semen, and embryo 
transfer is rare, (Barkema et al.,2001; Drew et al., 2002; Niskanen and Lindberg, 2003; Ståhl 
et al., 2005; Ståhl et al., 2007; Rikula et al., 2008; Bielanski et al., 2013; Ridpath, 2013). As 
PI cattle are by far the most important sources of infection, they are supposed to be the origin 
of iatrogenic infections. During their life, they can contract cp BVDV infection from cattle 
suffering from MD, or their own ncp BVDV can produce cp BVDV by recombination or 
mutation (Becher et al., 2001; Ridpath, 2003; Peterhans et al., 2010). At that moment cp and 
ncp BVDV exist together in the same animal and this can lead to the development of MD, a 
highly fatal form of BVD occurring mostly in cattle under two years of age (Brownlie et al., 
1984; Houe, 1992a; Bachofen et al., 2010). However, more than 10% of PI animals survive 
longer than 2 years (Presi et al., 2011). When pregnant, their offspring will always be PI as 
well (Moennig and Liess, 1995). 
Prolonged testicular infection 
The third form of BVDV infection is rare and of limited epidemiologic significance. 
When bulls become TI, the semen of a minority remains BVDV-positive during at least 11 
weeks and over 2 years (Voges et al., 1998; Niskanen et al., 2002; Givens et al., 2009). 
Experimental transmission of BVDV through semen of these bulls did however not infect 
other cattle (Givens et al., 2009; Givens and Marley, 2013). Despite the minimal risk of 
transmission, repeated detection of BVDV in bovine semen indicates that the bull should not 
be used for breeding or artificial insemination. A European Union directive (Council 
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Directive 2003/43/EC) stipulates that prior to the initial dispatch of semen from BVDV 
seropositive bulls, a semen sample from each animal shall be subjected to a virus isolation or 
virus antigen ELISA test for BVDV. 
Immunotolerance and immunosuppression 
Intriguingly, the same virus, ncp BVDV, causes immunosuppression in TI cattle, whilst 
large numbers of PI animals can survive during months or years without clinical disease. 
Those animals remain healthy not because the host became resistant to the virus, but rather 
the virus evolved mechanisms to increase the tolerance of its own host without the need to 
reduce the ncp BVDV burden that would otherwise decrease the chance of transmission to 
new hosts (Peterhans and Schweizer, 2013). In PI animals both the innate and adaptive 
immunity against the infecting BVDV strain are suppressed. Down-regulation of the 
interferon response against the infecting strain plays a key role in the mechanism of 
immunotolerance. In contrast, when PI animals become infected with other virus species, 
non-related BVDV strains, or other infectious agents, the interferon modulation will not be 
inhibited, and the hosts organism will start an immune response against the infecting 
organism. The same reaction is provoked at transient infections of susceptive cattle. BVDV 
impairs the immune reaction in TI cattle by interacting on several levels: lympho- and 
neutrophils, macrophages, and cytokines. BVDV causes lymphoid cell death and reduced 
function in the remaining lymphoid cells (Ridpath, 2010b). Unlike in the case of persistent 
BVDV infection, the immunosuppression in transiently infected cattle is not primarily caused 
by down-regulation of the interferon response.  
Conclusion 
The brief outline of the pathogenesis shows that the BVDV is a very well skilled virus. 
To enhance chances of survival, most viruses have only one possibility: “hit and run”, or 
“infect and persist”. The BVDV has mastered both strategies. When naïve hosts are available, 
PI cattle can (transiently) infect many animals over a short period of time. On the other hand 
BVDV can survive in the absence of susceptible individuals by infecting cattle persistently. 
Moreover, the rapidly changing genome is an additional advantage for survival. 
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Prevalence 
Cattle 
BVDV infection is endemic in cattle populations worldwide (Houe, 1999; Moennig et al., 
2005; Ridpath, 2010a). Prevalence of PI animals never exceeded 2% of the cattle population 
(Houe 2003), whilst seroprevalence can reach high levels. In Ireland, for example, 98.7% of 
non-vaccinating herds were seropositive in 2009 (Cowley et al., 2012). Seroprevalence of 
Swiss cattle was estimated to be 100% at the herd level and 60% at the animal level 
(Rufenacht et al., 2000). 
A recent study indicated that almost half of the Belgian cattle herds have seropositive 
young stock (Sarrazin et al. 2013a). In another study, circulation of BVDV was demonstrated 
in 93% of tested Belgian veal calf units and seroconversion to BVDV took place in 57% of 
the calves (Pardon et al., 2012).  
Other species 
Persistent BVDV infection can develop in at least eight other species: sheep, goats, pigs, 
alpaca, white-tailed deer, eland, mouse deer, and American mountain goat (Bachofen et al., 
2013). Although they are not considered as reservoirs of BVDV, these animal species may 
play an undesired role in eradication programmes. This is the case for small ruminants in 
particular, as spill-over of BDV from small ruminants to cattle is possible. More expensive 
tests can differentiate BDV from BVDV, but BVDV tests suitable for mass testing do not 
clearly differentiate between antibodies to the two viruses. Therefore, cross infections can 
interfere when monitoring for freedom of BVDV in cattle (Strong et al., 2010).  
Clinical features 
Describing the clinical presentations of BVDV infection is complicated because of four 
reasons.  
1. The clinical signs are numerous and extremely varied; 
2. Clinical presentations of BVDV infections can change over time because of 
genetic shift in BVDV-strains (Evermann and Ridpath, 2002); 
3. The majority of the clinical signs are not typical for BVD; 
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4. One cannot expect to find all of the different symptoms in one herd or during one 
outbreak. 
The severity of the clinical signs varies from very mild, over severe to lethal disease 
(Baker, 1995; Brownlie, 2004; Evermann and Barrington, 2005). Depending on the virulence 
of the strain, only the lymphoid tissue, or several organs become infected (Bolin and Ridpath, 
1992). Furthermore, the immune and reproductive status of the host, age of the host, and 
concurrent infections determine the clinical features (Ridpath, 2010a). Because of this 
variation, recognizing BVD by its clinical presentations is a challenge for the bovine 
practitioner (Lindberg and Alenius, 1999; Ridpath, 2003; Evermann and Barrington, 2005).  
Postnatal transient infection  
1. Acute infection  
It has been estimated that 70-90% of acute infections with BVDV in immunocompetent, 
seronegative cattle passes with only mild fever and leucopenia (Baker, 1995; Evermann and 
Barrington, 2005). Nevertheless, it has to be emphasized that despite the infection passing 
subclinically, immunosuppression over a short period is evident in these cattle (Wilhelmsen 
et al., 1990; Walz et al., 1999; Brackenbury et al., 2003; Ridpath, 2010b; Chase, 2013). This 
may result in other diseases, by giving the opportunity to other pathogens to secondarily 
infect the animal. Moreover, both clinical and subclinical BVDV infection may be 
accompanied by reduced fertility, originating from early embryonic death and impaired 
function of ovaries and testicles (Muñoz-Zanzi et al., 2004; Brock et al., 2005; Grooms et al., 
2006).  
Some TI cattle show rather mild clinical signs, such as fever, leucopenia as well as 
depression, anorexia, oculo-nasal discharge, oral lesions, diarrhoea, and decreased milk 
production. Obviously, also these animals can undergo secondary infections. 
More rarely, transient BVDV infection causes peracute outbreaks with fever, pneumonia, 
sudden death, and high mortality rates. These outbreaks have occurred mainly in North 
America (Corapi et al., 1990; Pellerin et al.,1994; Carman et al., 1998) but a few European 
cases have been described as well (David et al., 1994; Amiridis et al., 2004; Doll and 
Holsteg, 2013; Moen, 2013). The three predominant symptoms of experimental acute severe 
BVDV infection are: fever, low white blood cell count, and low blood platelet count (Walz et 
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al., 1999; Ridpath et al., 2006). Haemorrhagic Disease (HD) is often one of the clinical 
features of acute outbreaks of BVD. Potential clinical signs are bloody diarrhoea, epistaxis, 
hyphema (blood in anterior eye chamber), bleeding from injection sites, pyrexia, and death. 
Most HD cases were associated with BVDV2 (Evermann and Barington, 2005) and 
thrombocytopenia is rarely associated with BVDV1 (Blanchard et al., 2010).  
The most complex group of clinical presentations encompasses those caused indirectly by 
immunosuppression during transient infection. By concomitant infection with BVDV, the 
symptoms of other infectious diseases can become more severe and treatment results 
disappointing. Co-infections cause increased economic losses by important diseases like 
Bovine Respiratory Disease (BRD), salmonellosis, mastitis, and other infectious diseases. 
The effect of co-infection can both be a consequence of the immunosuppression that 
accompanies acute BVDV infections and predisposes to secondary infections, and of 
increased virulence of other pathogens caused by synergy in co-infections (Ridpath, 2010b).  
Despite the name “BVDV” it is generally accepted that most of the economic damage by 
BVDV infection is caused by reproductive disorders and respiratory disease. BVDV plays a 
role in the BRD syndrome (Moerman et al., 1994; Richer et al., 1998; Martin et al., 1999; 
Fulton et al., 2000a; O’Connor et al., 2001; Fulton et al., 2002; Booker et al., 2008; Pardon et 
al., 2012). A synergistic effect has been shown for co-infections of BVDV and bovine 
respiratory syncytial virus (Brodersen and Kelling, 1998; Brodersen and Kelling, 1999; Liu et 
al., 1999), infectious bovine rhinotracheitis virus (Castrucci et al., 1992), Parainfluenza-3 
virus (Aly et al., 2003), Mycoplasma bovis (Haines et al., 2001; Shariar et al., 2002), and 
Mannheimia haemolytica (Booker et al., 2008). Although the effect of co-infection of BVDV 
with other pathogens is believed to be the most important effect of BVDV on respiratory 
disease (Ridpath, 2010b), BVDV can also cause infections in the respiratory tract of cattle as 
a single agent (Baszler et al., 1995; Baule et al, 2001; Liebler-Tenorio et al., 2002). Under 
experimental conditions however, infections with most strains of BVDV alone pass without 
clinical signs or with mild disease, but respiratory disease can be one of the clinical results. 
Still it remains difficult to distinguish between the direct effect of BVDV on the respiratory 
tract and the effect of secondary infections caused by primary BVDV infection (Ridpath, 
2010b).  
Chapter 1                                                                                                                  General Introduction 
23 
 
Concomitant BVDV infection can also aggravate the outcome of enteric diseases such as 
salmonellosis (Daly and Neiger, 2008), paratuberculosis (Thoen and Waite, 1990) and 
rotavirus infection (Kelling et al., 2002). 
Mastitis is a very important infectious disease in cattle. Transient BVDV infections are 
believed to facilitate new or aggravate secondary intramammary infections with mastitis 
pathogens causing clinical or subclinical mastitis. Under field conditions, this issue has 
previously been investigated (Niskanen et al., 1995). With regard to the potential positive 
association between BVDV infections and bulk milk somatic cell count, some researchers 
have found a relationship (Lindberg and Emanuelson, 1997; Beaudeau et al., 2005; Voges et 
al., 2008), others have not (Waage, 2000; Berends et al., 2008). 
2. Acute infection in pregnant cattle 
As shown in Figure 2, the outcome of foetal BVDV infection depends on the stage of 
gestation. 
 
Figure 2. Schematic representation of foetal BVDV infection and its consequences. 
Adapted from Dirksen, 2002. 
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 In susceptible pregnant cattle, BVDV infection can cause the same clinical features as in 
non-pregnant cattle. In addition, viraemia can easily lead to placental infection (Frederiksen 
et al., 1999). Abortion or early embryonic death may occur from the resulting placentitis. As 
a result, and by negative effects of BVDV on ovarian function, the conception rate of a herd 
can decrease substantially (Houe, 2003). Between days 75 and 150 of gestation BVDV 
infection can cause congenital defects of the foetus (Blanchard et al., 2010) with the same 
clinical appearances for both PI and immunocompetent foetuses. Since the risk period for 
congenital malformations (day 75 until 150) does not entirely coincide with the risk period 
for becoming PI (day 30 until 125), it has to be emphasized that congenital defects can exist 
in both PI and TI calves (Figure 2). Finally, foetal infection can also cause birth of weak 
calves (Blanchard et al, 2010) 
From about 90 days of pregnancy onwards, some foetuses can become 
immunocompetent, others remain susceptible to PI until day 125 of pregnancy. Infection with 
BVDV at that stage and later in gestation will not result in PI calves, but the foetus can 
become TI with BVDV. Although most foetuses infected after they became immuno-
competent will be born as normal calves without symptoms, they still are susceptible to 
developing congenital malformations. Most frequently reported are growth retardation and 
the oculo-cerebellar syndrome. Characteristic for the latter are loss of equilibrium or eye 
disorders such as blindness by retinal atrophy or dysplasia, microphthalmia, cataract, and 
opaque spots on the cornea (Baker, 1995). Other congenital disorders have been attributed to 
intrauterine BVDV infection: hydrocephalus, hypomyelinogenesis, thymic hypoplasia, 
pulmonary hypoplasia, alopecia, hypotrichosis, brachygnatism, arthrogryposis, and other 
skeletal abnormalities (Baker, 1995; Blanchard et al., 2010). Furthermore, it has been 
reported that calves infected in late gestation can suffer from this BVDV infection after birth. 
During the neonatal period they are at increased risk of severe illness compared with calves 
without congenital BVDV infection (Barber et al., 1985; Munoz-Zanzi et al., 2003). 
The most important effect of acute infection of pregnant cattle is the fact that these dams 
most likely will give birth to a PI calf when the foetus has been infected between days 30 and 
125 of gestation. 
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Persistent infection  
In the case of persistent infection, the clinical signs can be divided into MD and non-MD 
cases. Clear clinical differentiation between MD and non-MD cases is not always possible, 
but simultaneous isolation of both biotypes of BVDV, ncp and cp, proves an animal to suffer 
from MD (Bachofen et al., 2010).  
MD is a sporadic syndrome that only occurs in PI animals, usually from the age of three 
months onwards (Houe, 1992a; Bachofen et al., 2010). Although MD generally occurs before 
two years of age, up to 10% of PI cattle detected in the Swiss eradication programme were 
older than 2 years (Presi et al., 2011). The MD syndrome is less frequently reported than it 
used to be, probably because PI cattle currently are more often detected and culled before 
contracting MD (Lindberg and Houe, 2005). Not all PI cattle die from MD, as they may be 
slaughtered as bull calves, or die from non-MD-related causes. Some may survive until 
adulthood, but are culled because of poor performance. The clinical signs of MD are fever, 
anorexia, tachycardia, polypnea, and profuse watery diarrhoea, often characterized by the 
presence of mucosal shreds, fibrinous casts, and blood (Evermann and Barrington, 2005). 
Tenesmus often accompanies the diarrhoea. Furthermore, erosions and ulcers may be present 
on the tongue, palate, and gingiva. Oral papillae may be blunted and haemorrhagic. 
Sometimes epithelial erosions are found in the interdigital regions, and coronary bands. 
Blood analysis often reveals neutropenia and thrombocytopenia. The mortality rate 
approaches 100%, but some animals survive, only to suffer from chronic MD (Loehr et al., 
1998). 
PI-cattle that have not (yet) developed MD can look healthy without symptoms, or show 
growth retardation (Bachofen et al., 2010). They also can suffer chronic or recurrent intestinal 
and/or pulmonary symptoms (Loneragan et al., 2005; Ridpath, 2010b) and, occasionally, 
dermatological, neurological or haematological disorders (Bachofen et al., 2010). Similar to 
TI cattle, PI animals can suffer from HD and congenital malformations.  
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Economic consequences of BVDV infection 
Economic consequences at the herd level 
The economic effect of BVDV infection highly depends on the risk of new infections and 
on the strain of virus involved (Houe, 1999). Most losses are a result of transient infections 
(Ridpath, 2005) and BVDV can affect the economic results of a herd in different ways (Houe, 
2003; Gunn et al, 2004; Evermann and Barrington, 2005; Fourichon et al., 2005):  
 Immunosuppressive effects of the virus at postnatal infection; 
 Effects of abortion and stillbirth; 
 Effects of postnatal infections on cattle at reproductive age and delayed rebreeding; 
 Congenital infections leading to calves with congenital defects and growth  
  retardation; 
 Congenital infections resulting in PI calves; 
 Long-term survivability of PI heifers leading to future PI calves, mortality, and  
  increased replacement costs. 
The economic damage caused by BVDV can vary substantially because of the 
multiplicity and variations in severity of the symptoms mentioned above, and the interaction 
with other pathogens. Furthermore, management factors and structure of the herd play an 
important role. For example, the outcome of BVDV infection can be disastrous in herds with 
a concentrated seasonal calving pattern. In contrast, small herds can become self-cleared of 
the infection with hardly any damage (Ståhl et al., 2008). As a result, a “herd level BVDV 
outbreak” is hard to define and losses are difficult to calculate (Lindberg et al., 2006). 
Moreover, some researchers are very doubtful about the existence of true subclinical BVDV 
infection (Evermann and Barrington, 2005). Nevertheless, calculation models have been 
worked out to estimate the economic consequences of the disease at the herd level. Most of 
the studies were focused on dairy herds. It was indicated that the costs of a BVDV infection 
vary between 21 and 135€ per dairy cow per year in case of “classical” outbreaks, where 
most transient infections go unnoticed, and most losses are due to reproductive disorders and 
PI animals (Fourichon et al., 2005; Valle et al., 2005; Lindberg et al., 2006). Outbreaks where 
BVDV infection stimulates concurrent infections, or with highly virulent strains have been 
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estimated to cost more than 340€ per dairy cow in the outbreak herd (Lindberg et al., 2006). 
Losses in Scottish beef herds were estimated at 58€ per cow per year (Gunn et al., 2004). 
Economic consequences at the regional or national level 
In countries where BVDV infection is systematically traced for eradication purposes, it 
has been evidenced that ongoing BVDV infection is often associated with discrete non-
specific clinical signs (Fourichon et al., 2005). Since these discrete effects are often not 
included in the calculations, losses may be underestimated (Valle et al., 2005) and obtaining 
exact figures of the consequences for the cattle industry is difficult.  
Overall, most estimations of the losses at the national level range between 7.5 and 30 
million € per million calvings (Houe, 2003). In Norway, BVDV was almost eradicated after 
10 years of systematic BVDV control. At that moment, the profits of the BVDV eradication 
were estimated 17.8 million Euros for the entire country, whereas the costs of the eradication 
programme were 6.7 million Euros (Valle et al., 2005). The authors suggested that the profits 
might have been underestimated, because of the often low-grade chronic effects of BVDV 
being spread out over time and therefore hard to identify as effects of BVDV. The annualised 
benefits of eradicating BVDV from Ireland have been predicted to exceed the costs by a 
factor of 5 in the beef sector and a factor of 14 in the dairy sector The corresponding pay-
back periods were 1.2 and 0.5 years respectively (Stott et al., 2012). 
The beneficial effects of BVDV control may exceed the direct economic effects. Public 
funding to support systematic BVDV control programmes can be justified on the basis of 
expected wider social benefits, such as animal welfare and reduction of antimicrobial use 
(Valle et al., 2005; Lindberg et al., 2006; Stott and Gunn, 2008; Stott et al., 2012). Currently, 
several European countries have started programmes to limit the use of antibiotics in cattle 
and other livestock. BVD control helps to achieve this objective, as reducing the clinical and 
subclinical effects of BVD has public health benefits by reduced veterinary treatments 
(Saatkamp et al., 2005). Furthermore, large scale control schemes may have beneficial effects 
on the national surveillance capacity in that they can both be a driver for developing more 
cost-effective infrastructure for surveillance, and may serve as a basic source of samples for 
running other analyses. 
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Diagnosis  
Because so many different types of clinical presentation are associated with BVDV 
infection, a diagnosis on the basis of history, clinical signs, and post mortem examination can 
only be considered presumptive. Accurate and definitive detection of BVDV infections 
depends on laboratory diagnosis (Goyal, 2005) .  
Tests commonly used in BVDV control 
A variety of test methods is available, but only a few tests are routinely used in BVDV 
control at the herd, regional, or national level: antibody-Enzyme Linked ImmunoSorbent 
Assays (ELISA), antigen-ELISA, and Reverse Transcriptase Polymerase Chain Reaction 
(RT-PCR) tests.  
The presence of antibodies can be demonstrated by ELISA. Indirect antibody ELISA can 
be used for semi-quantitative measures on serum, individual milk and bulk milk samples 
(Houe et al., 2006). 
The tests commonly used for detecting presence of BVDV are BVDV antigen ELISA and 
RT-PCR. BVDV antigen ELISAs are appropriate for testing individual samples of blood, 
serum, milk, and ear tissue. The ELISA actually used in Belgium is an ELISA that detects the 
Erns glycoprotein, a part of the envelope of BVDV. Presence of BVDV-RNA can be 
demonstrated by RT-PCR analysis. The latter test is also suitable for detecting BVDV-RNA 
in matrixes that might contain low quantities of virus such as bulk milk, pooled samples of 
serum and blood, or other biological material. For using the RT-PCR as a quantitative test, 
the cycle threshold (Ct) value can be measured as an indicator of the number of viral copies 
present in the sample. In this way the PI status could be distinguished from the TI status 
(Hanon et al., 2012). It is still under discussion if this method may be used to diagnose PI 
animals on the basis of a single blood sample. Therefore, cut-off values have to be 
determined. 
The performance of the currently available diagnostic tests for BVDV is good (Letellier 
and Kerkhofs, 2003; Mars and Van Maanen, 2005; Sandvik et al., 2005), but there is room 
for improvement. Nevertheless, sensitivity and specificity may vary depending on the aim the 
tests are used for (Houe et al., 2006). 
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The so called “diagnostic gap” is one of the potential causes of false negative results 
when testing calves under two months of age for BVDV (Fux and Wolf, 2012). The presence 
of high titres of maternal antibodies in such neonatal calves may influence the results of 
virological tests, and cause false negatives in antigen ELISA performed on individual blood 
and serum samples, and even in PCR tests on pooled blood samples (Martin Beer, personal 
communication). Albeit rarely, false negative results caused by maternal antibodies can also 
occur when using antigen ELISA on ear notch samples (Presi et al., 2011; Fux and Wolf, 
2012). The sensitivity of an Erns antigen-ELISA used on ear tissue in a regional control 
programme in Austria was estimated 97.3% (Oettl et al., 2010). Only PCR tests are not 
disturbed by the presence of colostral antibodies when used on individual blood, individual 
serum and ear notch samples. On the other hand, also false positive results cannot be 
excluded, as some tests detect other pestiviruses such as BDV (Letellier and Kerkhofs, 2003; 
Cranwell et al., 2007; McFadden et al., 2012).  
Practical applications of the tests in BVDV control 
Despite the availability of highly sensitive and highly specific diagnostic techniques, the 
suitability of a diagnostic test in any given phase of a control programme is largely dependent 
on the specific objectives of that particular phase (Houe et al., 2006).  
Laboratory techniques are strategically used to achieve three main objectives (Houe et al., 
2006): 
1 Initial tests to allocate a herd status; 
2 Follow-up tests to identify BVDV infected animals in infected herds; 
3 Continued monitoring to confirm BVDV-free status.  
For predicting the presence of PI animals in a herd, testing of bulk milk by an indirect 
antibody-ELISA can be used (Houe et al., 2006). As the level of BVDV-antibody in bulk 
milk correlates well with the prevalence of seropositive cattle, the sensitivity of this method 
is close to 1 in herds not vaccinated for BVDV, whereas the specificity is lower. Despite the 
high sensitivity, false negative results will occasionally be obtained for recently infected 
herds. A repeated bulk milk test a few months later will solve the problem (Houe et al., 
2006). Another option for determination of herd statuses is testing cohorts of young stock, 
using the so called “spot test”. The spot test is restricted to blood samples from five to ten 
animals between eight and twelve months old to be examined for antibodies to BVDV. 
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Moreover, this test is the tool of choice to obtain more certainty about the presence of a PI 
animal in the herd when there is a suspicion of BVDV infection (Houe 1992b; Pillars and 
Grooms, 2002; Houe et al., 2006; Booth and Brownlie, 2012). Combining bulk milk serology 
with a spot test enhances the sensitivity and specificity to diagnose a PI animal in a herd, 
since most PI cattle are younger than 2 years and it can take some time before these young 
animals infect the lactating animals or become lactating themselves. Furthermore, both 
above-mentioned serological methods become more reliable by repeating them (Houe et al., 
2006; Booth and Brownlie, 2012). Serological testing of first calvers’ milk can be used to 
obtain additional information on the herd status, especially in areas where BVD is endemic 
and where, as a result, serological testing of bulk milk will be positive in most herds (Valle et 
al., 2005). 
RT-PCR and antigen-ELISA are appropriate methods for identifying BVDV infected 
animals. Still, because of the high cost, a RT-PCR test is only sporadically used for testing 
individual animals in the field. In contrast, RT-PCR tests on pooled blood samples and bulk 
tank milk are popular for detection of PI animals at the herd level. If the pool is positive, the 
cheaper antigen-ELISA is used on the individual samples of the pool to identify the PI 
animal(s) (Hanon et al., 2012).  
The methods of continuous monitoring used to confirm BVDV-free status are essentially 
the same as those used to establish initial herd status (Houe et al., 2006). However, one has to 
realize that herds that have recently eradicated BVDV still have high BVDV-antibody titres 
in the bulk milk due to the persistence of BVDV-antibodies in milk following natural 
infection (Houe et al., 2006; Booth et al., 2013b). Therefore, during the period shortly after 
removal of PI animals from a herd, serological testing of young stock should be preferred to 
bulk milk serology (Houe et al., 2006).  
Antigen-ELISA are also used for individual testing at suspicion of BVD based on clinical 
presentations, or for testing small groups of cattle. Paired sera can be tested by antibody-
ELISA to diagnose recent viraemia in individual cattle.  
Correct interpretation of the results of all tests is highly important for the diagnosis. For 
instance, it is important to know that a PCR positive bulk tank milk sample is highly reliable 
for detection of a PI animal among the lactating cattle, but it has not been proven that it is 
suitable for detecting the presence of a few TI lactating cows or heifers (Drew et al., 1999; 
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Renshaw et al., 2000). Furthermore, samples from individual cattle can be RT-PCR positive 
during an extended period after infection but this does not always mean that active virus is 
still present (Givens et al., 2009). To determine the PI status of an animal, two samplings at a 
three week interval are needed for demonstrating persistent viraemia. As it might produce 
false positive results, RT-PCR has to be excluded when testing for the second time, in 
particular when the test is meant for legal use.  
Post mortem examination 
MD can be diagnosed by post mortem macroscopic and histologic examination. Typical 
lesions of MD are necrotizing ulcers and erosions throughout the gastrointestinal tract, 
necrosis and haemorrhages in the Peyer’s patches (Evermann and Barrington, 2005). 
PI animals not suffering from MD cannot be detected by routine histopathology. 
Importantly, viral antigens are weakly expressed in PI animals in tissues typically part of a 
post mortem exam (Dubovi, 2013). Therefore, it is important to select the appropriate tissue 
and test to diagnose BVDV infection. Tissues of choice for diagnosis by 
immunohistochemistry or virus isolation are tonsils, retropharyngeal lymph nodes, 
mesenteric lymph nodes, ileal Peyer’s patch, skin, and spleen (Liebler-Tenorio et al., 2006).  
control 
Every BVDV control programme, be it at the herd, regional, or national level, has to 
consist of a combination of different measures (Ridpath, 2013). The three pillars on which 
each programme should be based are: biosecurity, detection and eradication of PI cattle, and 
monitoring (Figure 3). Vaccination can complete the programme as a potential fourth 
component (Lindberg and Houe, 2005).  
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Figure 3. The three principles of systematic BVDV control as stated by Lindberg and Houe 
(2005), with vaccination as an optional fourth element. 
 
As the probability for transmission of the virus by the continuously shedding PI animals 
is very high, and the duration of the infectious period is lifelong, it is clear that PI animals are 
key to successful BVDV control. They have to be detected and removed, and generation of 
new PI calves has to be interrupted by preventing foetal infection in early gestation (Lindberg 
and Houe, 2005). Nevertheless, it has been stated in some studies that TI cattle also might 
play a role in maintaining the BVDV infection (Moerman et al., 1993; Moen et al., 2005). 
Such claims however, have to be supported by thorough evidence to prove that it is not due to 
insufficient detection of PI animals (Lindberg and Houe, 2005).  
Control at the herd level 
In Belgium, where there is no orchestrated regional or national approach to BVDV 
control in place today, voluntary control is carried out at the herd level. Figure 4 presents the 
strategy recommended by the Belgian Animal Health Services and Faculties of veterinary 
medicine.  
 
 
Vaccination 
Monitoring 
Removal of PI 
Biosecurity 
Chapter 1                                                                                                                  General Introduction 
33 
 
 
 
Figure 4. Herd level tracing procedure for persistently BVDV infected animals as 
recommended by Belgian Animal Health Services and Faculties of veterinary medicine. The 
spot test consists of blood samples from 5-10 cattle between 8 and 12 months old, to be 
examined for antibodies to BVDV.  
When for some reason a herd is suspected of infection, or when the farmer wants to know 
the BVDV status of his herd, blood samples are collected for a spot test (Houe, 1994). It is a 
useful tool for the veterinarian to convince the client to start screening for PI animals. When 
60 % of the animals included in the spot test are seropositive, the presence of one or more PI 
animals in the herd is very likely (Houe, 1994; Houe et al., 2006). In contrast, when fewer 
than 60 % of the animals are seropositive, the practitioner will explain to the client that 
possibly no PI animals will be found in the herd. Relying on this information, the owner can 
decide whether to start detecting PI animals. If not, the spot test should be repeated 3 months 
later.  
Spot test 
Spot test 60% or more 
positive 
Spot test entirely negative 
 
RT-PCR on bulk tank milk 
and pooled blood 
RT-PCR positive 
RT-PCR negative 
Individual Ag ELISA 
Test newborns until one year 
after removal of PI last found 
Repeat every 6 months 
 
Spot test <60% positive 
 
Repeat after 3 months 
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Detection of PI animals commences by testing every animal in the herd, using whole 
blood or serum and bulk tank milk samples. The blood samples are gathered into pools to be 
tested by RT-PCR. The number of samples in a pool depends of the sample matrix and the 
RT-PCR test used. The bulk tank milk sample is also tested by RT-PCR (Letellier and 
Kerkhofs, 2003). Only a fraction of each blood sample is used for RT-PCR testing. If a pool 
or a bulk tank milk sample tests positive, the remaining part of the blood sample of every 
individual belonging to that pool is investigated by an antigen ELISA to detect the viraemic 
animal(s) (Mars and van Maanen, 2005; Hanon et al., 2012). In the case of a positive bulk 
tank milk sample a blood sample is collected from each cow or heifer contributing to the bulk 
milk sample. When an individual test is BVDV positive, positive animals are tested again 
three weeks later to confirm persistent viraemia. 
Irrespective of the result, every newborn calf is tested for persistent viraemia from the day 
of whole herd sampling onwards until one year after removal of the last PI animal identified. 
As soon as the first BVDV carriers have been removed from the farm, vaccination of all 
cattle older than one year is recommended, as well as continued monitoring, which consists 
of conducting a serological spot test at 6 month intervals. 
Control at the regional/national level 
In countries without systematic BVDV control at the regional or national level, BVDV 
infection has continued to cause widespread disease and reproductive losses (O’Rourke, 
2002; Ridpath, 2012). In contrast, the systematic national programmes in Scandinavia 
(Moennig et al., 2005; Løken and Nyberg, 2013) and Switzerland (Presi et al., 2011) were 
successful. Since ear notch tests became available recently, more countries have followed, 
implementing a BVDV control programme based on ear notch sampling.  
When the Scandinavian countries started their control programmes at the end of the 
former century, the ear notch test was not yet available. Therefore, these programmes were 
based on initial antibody tests, followed by virus tests when a herd was suspected of housing 
PI cattle. The status of a herd was checked by regular spot tests and bulk milk testing (Løken 
and Nyberg, 2013). Once there was a suspicion of BVDV circulation in a herd, PI cattle were 
traced. A vaccination ban was part of the regulations, since vaccine antibodies produce (false) 
positive results in serological tests and, as a result, can cause interference with surveillance 
tests. Austria started control programmes based on the Scandinavian method (Rossmanith et 
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al, 2010). Switzerland imposed testing of all cattle young and old and a vaccination ban 
(Presi et al., 2011). In Ireland, Germany and Bolzano (Italy) newborn calves are tested and 
vaccination is allowed (Barret et al., 2011; Tavella et al., 2012). In Scotland different 
schemes of control are permitted, depending on the BVDV status of the herd (Voas, 2012). In 
some programmes PI animals are not allowed to be transported out of the herd and 
restrictions are implemented for suspected herds. Euthanasia or slaughter of PI cattle is not 
always obligatory. In all these countries or regions the importance of spreading information 
to farmers and veterinarians has been emphasized.  
Obviously, when testing is implemented with the intention of making herds free of the 
virus, it is important to prevent re-infection of herds. As introduction of a PI animal or a dam 
carrying a PI foetus is the most important risk of infection of a herd (Lindberg et al., 2006; 
Dubovi, 2013), preventing movements of such animals must be the core of any eradication 
scheme. The current national programmes (Germany, Ireland, Switzerland) rely on ear notch 
testing at birth. Once an animal is negative, it is considered non-PI for the rest of its life, 
although false negative ear notch tests are possible (Fux and Wolf, 2012).  
The role of vaccination in BVDV control 
Vaccines against BVDV exist since 1964 (Deregt, 2005). Both Modified Live Virus 
(MLV) and inactivated vaccines are available, but for the moment, no MLV vaccines are 
registered in Belgium. One particular BVDV vaccine exhibited Differentiating Infected from 
Vaccinated Animals (DIVA) properties, but only if combined with one particular BVDV 
antibody ELISA-test (Makoschey et al., 2007). Nevertheless, a true DIVA vaccine for BVDV 
is not available at the time of submission of this thesis. As a result, vaccine antibodies can 
cause false positive results in serological BVDV-tests. Most vaccines contain BVDV1. 
Vaccines can induce T cell responses and antibodies to multiple BVDV subtypes, but 
antibody titres are generally higher to the vaccine strain and to strains belonging to the same 
genotype or subgenotype (Fulton and Burge, 2000). For that reason, vaccines based on 
BVDV1 may not protect against BVDV2 infection (Brock and Cortese, 2001).  
A vaccination programme will not prevent all infections in individual animals (Ridpath, 
2013). For that reason, BVDV vaccination cannot, on its own, eliminate BVDV from 
populations (O’ Rourke, 2002; Lindberg and Houe, 2005; Ridpath, 2010a; Ridpath, 2013). 
Moreover, it is often the case that due to inappropriate use of the vaccine only partial 
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protection is achieved (Meadows, 2010).What vaccination can do is to reduce the incidence 
of acute and persistent infections in a herd or population. When used as a supplementary 
measure of biosecurity, in combination with detection of PI cattle and monitoring, 
vaccination can play a role in BVDV control, because it is effective in reducing the spread of 
BVDV. 
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Because of the ever-changing clinical presentations of BVD, it is difficult to convince 
farmers that the infections have an effect at the herd level. Most of them are even unaware of 
the presence of BVDV on their farm and, consequently, BVDV infection is often diagnosed 
only at a late stage. Experiences in the field indicate that farmers and veterinary practitioners 
continue to rely on clinical signs to detect BVDV. Moreover, when evaluating the farms wíth 
BVDV control, it often becomes apparent that the methods are inadequate.         
This doctoral thesis is aimed at addressing issues of misconception that hamper the 
advancement of BVDV control in a Belgian context, and thereby providing a greater 
understanding regarding constraints that may be present in other regions too.  
The specific aims of this thesis are: 
 To illustrate that a clinical diagnosis of BVD is difficult because of the diverse 
clinical manifestations. Exceptional pathology and clinical presentations associated with 
BVDV infections both in adult cattle and neonatal calves will be documented in three case 
reports (Chapters 3.1, 3.2, and 3.3).  
 To highlight a subclinical form of BVDV infection through looking for differences in 
bulk milk somatic cell counts between BVDV infected and non-infected herds (Chapter 4). 
 To assess whether BVDV management in Belgium sufficiently implements two 
essential elements of efficient BVDV control: detection of PI animals and monitoring 
(Chapter 5).  
Despite the availability of several BVDV vaccines and voluntary programmes to control 
the virus, BVDV infections in cattle herds continue to cause substantial economic damage to 
the cattle industry worldwide. Only those countries where a national or regional eradication 
programme has been brought into force, have succeeded in controlling BVDV. Therefore, a 
BVDV eradication plan has been designed for Belgium. In the general discussion of this 
thesis (Chapter 6), some recommendations are made for the future Belgian plan to control 
BVD and eventually eradicate BVDV by bringing together current general knowledge and 
findings originating from the present thesis.  
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All bovine viral diarrhoea virus (BVDV) strains can appear both as the cytopathic (cp) 
and the non-cytopathic (ncp) biotype. Although both can infect the foetus, only ncp BVDV is 
able to cause persistent infection (Brownlie and others, 1989). Furthermore, all offspring of 
persistently infected (PI) dams are PI (Liebler-Tenorio, 2005). In the field, cp BVDV strains 
are typically isolated from cases of mucosal disease (MD) or associated with the use of 
modified live vaccine (Ridpath, 2005). In cases of MD, both cp and ncp BVDV are present in 
the same animal. The incubation period takes two to three weeks in early-onset MD, but can 
be extended by months or years in late-onset MD (Brownlie and Clarke, 1993). MD usually 
affects animals aged six to 18 months, although occasionally it has been reported in calves of 
a few weeks old (Brownlie, 2004). This short communication reports the detection of cp 
BVDV in a 10-day-old calf during an outbreak of haemorrhagic diarrhoea.  
Between 2004 and 2007, sporadic cases of non-fatal haemorrhagic diarrhoea in neonatal 
calves occurred in a herd consisting of 60 Holstein-Friesian and 150 Belgian blue breeding 
cattle and their offspring. In 2007, the number of affected newborn calves increased, and two 
youngsters died at the age of five and six months from neurological disease. Because these 
animals were BVDV antigen ELISA positive at post-mortem examination, vaccination with 
two inactivated BVDV vaccines was begun. A farm-wide screening programme for PI 
animals was not carried out. All calves were routinely vaccinated at three months of age 
against bovine respiratory syncytial virus (BRSV), parainfluenza type 3 (PI3) virus , and 
BVDV (Rispoval Trivalent BRSV-PI3-BVD; Pfizer Animal Health), followed by a booster 
vaccination one month later. Furthermore, female young stock between eight and 24 months 
of age were vaccinated annually in one session with Pregsure BVD (Pfizer Animal Health). 
The colostrum management consisted of administering one litre of colostrum immediately 
after birth. All calves also received an oral solution of bovine antibodies against Escherichia 
coli (Locatim; Biokema Anstalt). From then on their ration consisted of milk only. Between 
January and May 2009, almost all neonatal calves were affected with haemorrhagic 
diarrhoea. One to two weeks after birth, the calves started showing fever as high as 40°C and 
haemorrhagic diarrhoea. Tests for coronavirus, rotavirus, and enterotoxigenic Escherichia 
coli were negative. When Cryptosporidium parvum was detected in faeces, all newborns 
received halofuginone (Halocur; Intervet) and the haemorrhagic diarrhoea resolved. 
However, calves still became ill, showing pneumonia, stomatitis, nasal discharge, excessive 
salivation, fever (40°C), and weight loss. Five calves died during this outbreak, but none of 
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these was examined post mortem. In May 2009, veterinarians from the Faculty of Veterinary 
Medicine, Ghent University, visited the farm. At that time, three calves from a group of 
seven, aged between 11 and 30 days, had been showing clinical signs since one or two weeks 
after birth. One calf was lethargic and had a diffuse, non-ulcerative stomatitis. Another calf 
suffered from pneumonia and a similar stomatitis. A third calf had survived a period of 
haemorrhagic diarrhoea, and was showing pneumonia as the only clinical sign at the time of 
the visit, which was 14 days after the onset of clinical signs. Body temperatures ranged 
between 39.8 and 40°C. Except for reduced fertility in adult cattle, no other signs of any 
disease were noticed.  
Blood samples from two healthy calves aged two and four days showed low IgG 
concentrations (4 and 8 mg/ml) in a semi-quantitative glutaraldehyde test, which indicated 
failure of passive transfer (Weaver and others, 2000). A bulk milk sample and blood samples 
from six calves were tested for BVDV by real-time RT-PCR as described previously 
(Letellier and Kerkhofs, 2003). An endogenous extraction/reaction control targeting bovine 
β-actin mRNA was performed on all samples. Validation of the test samples was performed 
by normalization of the BVDV results with the β-actin results using the method described by 
Toussaint and others (2007). No BVDV RNA was detected in the milk sample, but BVDV 
RNA was detected in four of the six blood samples collected from calves. Two BVDV RNA 
positive calves (calves 1 and 2) were showing signs of illness at sampling. When comparing 
the normalized values, the blood of a 10-day-old calf (calf 3) contained at least 104 RNA 
copies more than the samples from the other positive calves. Subsequent virus isolation 
detected cytopathic BVDV in the sample from calf 3; no virus was isolated from the samples 
of the remaining three calves. The isolated cytopathic BVDV was genotyped as BVDV1b by 
RT-PCR and sequencing (Letellier and others, 1999). 
Subsequently, all cattle in the herd older than two months were tested by antigen ELISA 
(BVDV Ag/Serum Plus Test, Idexx), but only one antigen-ELISA positive animal was found: 
the dam of calf 3. As this cow was the only viraemic animal detected and proved to be a 
contemporary of the two young stock with neurological signs that had been found to be 
BVDV viraemic in 2007, the farmer and his veterinarian suspected it of being PI. 
Consequently, this cow and calf 3 were removed from the herd immediately. No later 
sampling was done, so the PI status was implied rather than confirmed absolutely. 
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Nevertheless, this was a fair interpretation of these results. It was extremely likely that both 
the dam and its calf were PI. Both animals were apparently healthy. 
If PI animals are not removed, BVDV can continue to spread in vaccinated herds (Fulton 
and others, 2005; Ridpath, 2010). In the present case, BVDV circulation may have been 
further facilitated by the cows not being vaccinated. Moreover, with better maternal 
immunity, the calves might have stayed uninfected by BVDV. 
Because MD is uncommon in calves younger than one month of age (Torgerson and 
others, 1989; Evermann and Barrington, 2005; Bachofen and others, 2010), the presence of 
cytopathic BVDV in a 10-day-old calf is considered to be an extraordinary finding. As there 
are no modified live vaccines registered in Belgium, the presence of vaccine cytopathic 
BVDV could be excluded in this case. Given that the only other PI animal detected was the 
calf’s dam, which did not have MD, it is unlikely that the cytopathic BVDV in calf 3 came 
from another PI. A third plausible explanation is that the cytopathic virus may have 
originated from a persisting non-cytopathic biotype through exceptionally early genetic 
recombination. 
Experimentally, MD is described as developing no earlier than two weeks after infection 
of a non-cytopathic PI animal with a homologous cytopathic strain (Liebler-Tenorio and 
others, 2000; Liebler-Tenorio, 2005). Therefore, the cytopathic virus can be present before 
the onset of clinical signs. In the present case, neither persistent infection nor MD could be 
proven unarguably: the cytopathic BVDV-positive calf and his dam were removed 
immediately and non-cytopathic BVDV was not detected together with cytopathic BVDV in 
one animal.   
This report shows that cytopathic BVDV can be present in neonatal calves.  
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Abstract 
A calf developed skin bleeding on the second day of its life. It was referred to the clinic 
on suspicion of Bovine Neonatal Pancytopenia (BNP). Haematology showed extreme 
thrombocytopenia, a moderate anaemia, but no leucopenia. A PCR test on a heparinised 
blood sample was Bovine Viral Diarrhoea virus (BVDV) positive, as were the two BVDV 
antigen ELISA performed 3 and 10 weeks later. Non-cytopathic BVDV type 1b was isolated 
from the blood. The persistently (PI) BVDV infected calf recovered from haemorrhagic 
disease and continued to be healthy until euthanasia at 11 weeks of age. On the basis of the 
case history, BNP could be excluded from the differential diagnosis. This case illustrates that 
haemorrhagic disease is not exclusively associated with BVDV type 2 and that the clinical 
signs in neonatal calves infected with BVDV1b can be identical with the clinical presentation 
of BNP.  
Introduction 
Infection of cattle with bovine viral diarrhoea virus (BVDV) can have various clinical 
presentations, from non-clinical or mild disease to outbreaks of acute, severe disease with 
high mortality. Haemorrhagic disease (HD) is one of the potential clinical features, 
characterized by thrombocytopenia and an increased susceptibility to bleeding (Walz and 
others 1999). Although severe outbreaks of acute BVDV infection are commonly termed 
“haemorrhagic syndrome”, haemorrhages were not always among the clinical signs of these 
outbreaks (Carman and others 1998, Ridpath and Fulton 2009). In contrast to American 
BVDV type 2 strains, European BVDV type 2 strains have rarely been associated with HD 
(Ridpath 2005, Vilcek 2005). Recently, a North American BVDV type 2 strain was detected 
in Belgium, but HD was not among the clinical presentations (Letellier and others 2010). 
Furthermore, most cases of HD are associated with transient infections and HD in persistently 
infected (PI) cattle rarely has been reported (Dabak and others 2007). Calves of the latter case 
were older than 1.5 months and died of mucosal disease (MD). Here we report a case of 
spontaneous skin bleeding in a 2-day-old calf persistently infected with non-cytopathic 
BVDV type 1b and not suffering from MD.  
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Case report 
In June 2011, a 2-day-old Belgian Blue calf developed spontaneous skin bleeding and 
was transferred to the clinic on suspicion of Bovine Neonatal Pancytopenia (BNP). The 
farmer mentioned an increased frequency of neonatal diarrhoea and respiratory disease 
among the calves in the previous months, but no haemorrhages had been noticed among other 
cattle of the mixed beef and dairy herd. The calf was delivered by caesarean section, had 
received 4 litres of colostrum from its own dam and appeared to be healthy during the first 
day of life. BVDV vaccination had never been performed in the herd and the dam was 
homebred. 
On arrival the calf was depressed and showed melena and skin bleeding, not only from 
both ears due to ear tagging, but also on the back and legs. The mucosae were pale and 
petechiae and submucosal bleedings were found under the tongue and elsewhere on the oral 
mucosa. The body temperature was 39°C, pulse rate was 80 per minute and respiratory rate 
was 24 per minute.  
Haematology showed extreme thrombocytopenia (0 platelets/L), a moderate anaemia 
(PCV= 0.23 L/L), but no leucopenia (9.5x109/L). A PCR test performed on a heparinised 
blood sample taken on arrival was BVDV positive, as were two antigen ELISA on whole 
blood taken 3 and 10 weeks later (IDEXX BVDV Ag/Serum Plus Test, IDEXX Europe, 
Hoofddorp, The Netherlands). Non-cytopathic BVDV was detected at virus isolation from a 
whole blood sample taken on day 52. The isolated strain was genotyped as BVDV type1b by 
RT-PCR and sequencing (Letellier and others 1999). An EDTA blood sample from the calf’s 
dam was BVDV negative in the same antigen ELISA. 
Until day 14, the calf was treated with cefquinome (Cobactan® 2.5% w/v; Intervet) to 
protect it from secondary infections. From day 2 it was housed in strict isolation. Platelets 
and PCV normalized after 13 and 20 days respectively. The calf had a good appetite and 
looked healthy until it developed pneumonia with a fever peaking at 40°C at 37 days of age. 
After treatment with gamithromycin (Zactran 150 mg/ml; Merial) and ketoprofen (Ketofen 
10%; Merial) it recovered. From this point until euthanasia on day 77, the calf showed no 
further clinical signs of disease. The only reason for euthanasia was the persistent BVDV 
infection. On the farm, haemorrhages have not been recorded in any other stock to date. 
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Discussion 
As the calf had no initial fever and there were no other symptoms at the same time as the 
bleeding syndrome, haemorrhagic septicaemia and endotoxaemia could be excluded as 
potential causes of thrombocytopenia. Toxic agents were not suspected of having caused the 
haemorrhagia in this 2 days old calf, because plants like field melilot (Melilotus officinalis) 
and bracken fern (Pteridium aquilinum) need prolonged intake to cause bleeding syndromes 
and dicumarol, present in bracken fern and commercial rodenticides, does not lead to bone 
marrow depletion (Wang et al., 2007). Furthermore, until now thrombocytopaenia has not 
been described in cattle affected by hereditary bleeding syndromes (Steficek et al., 1993; 
Meydan et al., 2009; Shiraishi et al, 2002) . In 2008, BNP emerged in Europe as a cause of 
thrombocytopenia and leucopenia in neonatal calves (Pardon and others 2010). In this 
immunomediated disease allo-antibodies directed to calf leucocytes and bone marrow 
precursor cells are transferred to the calf through colostrum (Bastian et al., 2011; Bridger et 
al. 2011; Pardon et al 2011). Although it was demonstrated that the presence of the allo-
antibodies in colostrum was associated with vaccination with a particular BVDV vaccine 
(Sauter-Louis et al., 2012), only a small number of all calves that had received colostrum 
from vaccinated mothers developed BNP. It is assumed that the latter could be contributed to 
inherited factors (Deutskens et al., 2011). The present case calf had only received colostrum 
from its own dam. The cow was born and raised on the farm and BVDV vaccines had never 
been used in the herd. Moreover, colostrum from other herds never had been administered on 
this farm. For these reasons BNP could be excluded and persistent infection with BVDV type 
1b was considered to be responsible for the thrombocytopenia in the newborn calf.  
It has been suggested that some cattle could be viraemic for a longer period than the 
generally accepted 14 to 21 days (Collins et al., 2009). Therefore, a second blood sampling 
for antigen-ELISA was carried out on the present case calf 10 weeks after the first, to exclude 
the possibility of prolonged transient infection. Collins and co-workers found evidence of the 
presence of BVDV in blood of calves up to 3 months after infection, but these calves were 
Antigen ELISA negative at that stage. The fact that the present case calf was Antigen-ELISA 
positive at the second sampling proved that it was PI.  
Although persistently infected, the case calf showed two of the three predominant 
symptoms of experimental acute severe BVDV infection: fever, low white blood cell count 
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and low platelet count (Walz 1999; Ridpath and others 2006). Nevertheless, the case was 
exceptional for several reasons. First of all, the bleeding disorder was associated with a 
BVDV type 1 strain. To the authors’ knowledge, this has only been reported by Dabak and 
co-authors (2007) in older PI calves suffering from MD. Secondly, the present calf was much 
younger than previously reported for HD and the clinical presentation was indistinguishable 
from the clinical signs of BNP. Thirdly, the thrombocyte count returned to normal in spite of 
persistent viraemia. Therefore, a direct effect of the virus on thrombocytes seems unlikely. 
This finding is in line with the results of a study by Walz and co-workers (2005), who 
detected no significant difference in platelet counts between cattle PI with BVDV and control 
cattle. A potential hypothesis for the thrombocytopenia might be removal of virus containing 
thrombocytes or megakaryocytes after interaction with colostral antibodies, comparable to 
BNP pathogenesis (Deutskens and others 2011).  
Conclusion 
This case report illustrates that BVDV1b associated haemorrhages can occur in PI calves 
younger than one month, not suffering from MD at that stage of infection. As the clinical 
presentation was the same as for BNP, it is advisable to rule out BVDV infection in suspected 
cases of BNP.  
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Abstract  
 After three cows of a dairy herd had died from severe haemorrhagic diarrhoea, a fourth 
sick cow was transported to the clinic. Blood analyses revealed the complete absence of 
white blood cells, the presence of a type 1b strain of Bovine Viral Diarrhoea Virus (BVDV), 
and seroconversion to BVDV.  
Introduction 
Although infection with Bovine Viral Diarrhoea Virus (BVDV) usually manifests few 
obvious symptoms, intra-uterine or postnatal infection with the virus is able to provoke a 
wide range of symptoms in cattle (Brownlie, 2004). The consequences of intra-uterine 
infection include early embryonic death and abortion, congenital defects, and birth of 
persistently infected (PI) calves. Most of these PI cattle die from mucosal disease before they 
are 2 years old. During their life, they are a contagious source of BVDV infection. Because 
the virus impairs the immunity of infected animals in PI cattle, as well as at postnatal, 
transient infection (Chase et al., 2004; Ridpath and Fulton, 2009), BVDV infection can 
aggravate other diseases or make infected animals more susceptible to other diseases such as 
bronchopneumonia, diarrhoea, and mastitis (Liebler-Tenorio, 2005; Lundborg et al., 2005; 
Berends et al., 2008; Daly and Neiger, 2008; Diéguez et al., 2009). Alternatively, some 
BVDV strains induce direct damage to specific cells and tissues after postnatal infection, 
causing different syndromes. Postnatal BVDV infection has been described as the primary 
cause of respiratory disease (Hamers et al., 2000; Baule et al., 2001; Galav et al., 2007), and 
glomerulonephritis (Galav et al., 2007). Meningoencephalitis has also been reported as a 
result of a BVDV infection, but the authors could not determine whether the infection was 
transient or persistent (Blas-Machado et al., 2004).  
The occurrence of severe clinical disease during a BVDV infection has been attributed to 
particular and highly virulent BVDV strains (Bolin and Ridpath, 1992; Pellerin et al., 1994; 
Baule et al., 2001). Kelling et al. (2002) showed that experimental infection with a virulent 
strain resulted in severe clinical disease and prolonged viral excretion. Others suggest that the 
severity of the clinical outcome depends on the degree of viraemia during BVDV infection, 
as provoked by particular isolates of the BVDV (Walz et al., 2001). BVDV and other RNA 
viruses are able to create a large number of mutants. Some mutants that replicate faster may 
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dominate the mutant swarm, giving virulent virus with enhanced viral replication a 
competitive advantage over less virulent viruses. This could explain the periodic emergence 
of virulent BVDV that produces severe outbreaks of disease (Bolin and Grooms, 2004). 
Although it is BVDV type 2 that predominantly creates more severe symptoms, serious 
disease can result from a BVDV type 1 infection (Amiridis et al., 2004; Muskens et al., 2004; 
Vilcek et al., 2005) and, conversely, a type-2 infection can pass without serious clinical signs 
or even subclinically (Bolin and Grooms, 2004).  
In this article a case of periparturient BVDV type 1 infection with haemorrhagic colitis 
and proctitis in an adult cow is described.  
Case description 
Anamnesis 
In October 2008, 10 peripartum cows of a dairy herd (n=60), showed acute symptoms 
such as high fever, coughing, dyspnea, and occasional mastitis over a 20 day period. A few 
days later, 5 of the cows developed severe watery, yellowish diarrhoea, sometimes bloody, 
with pyrexia lasting up to one week despite combined antibiotic and anti-inflammatory 
treatment. All cows had calved over the last two weeks in calving pens adjacent to young 
cattle (Figure 1). Three cows suffering from severe diarrhoea died; the others slowly 
recovered.  
One 6-year-old cow was referred to the clinic 10 days after calving. She had developed 
high fever (41°C) the first day after parturition and had been recumbent. After several 
perfusions with calcium borogluconate (Calcii Borogluconas; Eurovet, Heusden-Zolder, 
Belgium), 500mL on consecutive days, she was able to rise again. 
Treatment consisted of marbofloxacin (Marbocyl® 10%; Vétoquinol, Aartselaar, 
Belgium), 2mg/kg body weight per day, tolfenamic acid (Tolfine®, Vétoquinol), 2mg/kg 
body weight, and calcium-borogluconate (Calcii Borogluconas; Eurovet), 500 mL over 3 
consecutive days. Despite this treatment, the diarrhoea and pyrexia (40.7 °C) persisted. 
Immediately before leaving for the clinic, the animal had received florfenicol (Nuflor®, 
Schering Plough, Brussels, Belgium), 20 mg/kg body weight, and meloxicam (Metacam®, 
Boehringer Ingelheim, Brussels, Belgium), 0.6 mg/kg body weight.  
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Figure 1. : The prepartum cows were housed in a pen adjacent to the pen of the 3-month-old 
calves. 
Clinical examination 
On arrival at the clinic, the cow was alert but anorectic and laying in sternal position, 
unable to rise, even after stimulation. The body condition was normal (Body Condition 
Score: 3.5), but skin turgor was decreased and mucous membranes were pale. The cow had a 
heart rate of 84 beats/min, respiratory rate of 64 breaths/min with abdominal breathing, and a 
rectal temperature of 37.5 °C. After fluid therapy the next day the temperature rose to 39.6°C. 
Fluid splashing sounds were present at simultaneous auscultation and succussion of the right 
flank. The faeces were liquid and contained a large amount of fresh blood. After cautious 
rectal examination, a large amount of fresh blood covered the disposable glove. No ulcerative 
lesions were found at the buccal mucosa, between the claws or on the teats. 
 
Diagnosis 
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The most remarkable result of the blood analysis was a complete absence of white blood 
cells (Table 1). Neither lymphocytes nor neutrophils were detected in a leukocyte count using 
the Poch-100IV Diff® (Sysmex, Hoeilaart, Belgium). Moreover, on a stained blood smear 
(Hemacolor®; Merck, Overijse, Belgium) only one neutrophil was found. Total and ionary 
calcium as well as potassium were low, probably caused by low intake or faecal loss due to 
diarrhoea or both. Lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and 
creatine phosphokinase (CPK) were increased, most likely due to recumbence-associated 
muscle injury. Total bilirubin and blood urea nitrogen were mildly increased.  
An antigen enzyme-linked immunoSorbent assay (ELISA) performed on a heparinised 
blood sample taken on the cow’s arrival at the clinic was BVDV positive; however, the same 
test produced a negative result on a sample taken 10 days later. After euthanasia of the cow, a 
previously frozen serum sample was examined. The real-time reverse transcription 
polymerase chain reaction (RT-PCR) as described previously (Letellier and Kerkhofs, 2003), 
showed the presence of BVDV type 1. Virus isolation from this serum sample, performed on 
Madin-Darby bovine kidney (MDBK) cells was unsuccessful, probably due to the short-lived 
and low level viraemia associated with transient BVDV infection. Bovine viral diarrhoea 
virus antibody ELISA performed at arrival and 10 days later demonstrated seroconversion.  
Paired sera (arrival date and 10 days later) were both negative for Salmonella dublin and 
Salmonella typhimurium. Culture of faeces material on Brilliant Green agar was Salmonella-
negative as well. Anaerobic culture of faeces on blood agar yielded Clostridium perfringens. 
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Hematologic results   
 
  
Biochemical results a 
 
 
    
 
Packed cell volume   
 
38%                      
 
Total serum protein    
 
 
65 g/litre (60-80) 
 
Red blood cells         7.97x109/litre       Total bilirubin            17 μmol/litre (2.5-6) 
 
White blood cells      0.00x109/litre       Ureum (BUN)            13.6 mmol/litre (3-8) 
 
 0% neutrophils     Creatinine   4.7 mg/dl (0.6-1.8) 
 
 0% lymphocytes   GPT/ALT                   37 mU/litre (<10)        
 
Thrombocytes 142x109/litre        AST/GOT                  375 mU/litre (24-142) 
  LDH >4000 mU/litre (692-1445) 
  CPK 487 mU/litre (150) 
  AP 147 mU/ml (150) 
  GGT                              15 mU/ml (<30) 
  Mg++ 1.38 mmol/litre (0.6-1.0) 
  Na+ 130 mmol/litre (132-152) 
  K+ 2.9 mmol/litre (3.5-4) 
  Ca++ ionic 0.54 mmol/litre (1.0-1.25) 
  Total Ca++ 0.99 mmol/litre (2.0-2.5) 
a The reference intervals are shown in parentheses. 
ALT – alanine aminotransferase, AST – aspartate aminotransferase, LDH – lactate dehydrogenase 
CPK – creatine phosphokinase, AP – alkaline phosphatase, GGT – gamma-glutamyl transferase  
BUN – blood urea nitrogen 
 
Table 1. Results of the blood analysis of the cow at arrival in the clinic. Most remarkable are 
the total absence of white blood cells and the hypocalcaemia. 
 
Treatment and clinical evolution 
On admission the cow received 500 ml of a 27.9% calcium perfusion (Calciumboro-kel®, 
Kela Laboratoria, Sint-Niklaas, Belgium) and was transported to the stable. The animal 
received a continuous IV drip in a 5% glucose polyionic isotonic solution (413g NaCl, 18.5g 
KCl, 22g CaCl2 and 10g MgO2 in 10 litres of distilled H20). Enrofloxacin (Baytril® 4%, 
Bayer, Brussels, Belgium), and flunixin meglumin (Finadyne®, Intervet-Shering Plough, 
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Brussels, Belgium) were administered intravenously for 5 and 3 days, respectively. Potassium 
(160 mEq/day) was supplemented for one week in 500 ml of a 5% glucose polyionic solution, 
because the animal remained hypokalaemic. Three episodes of recurrent hypocalcaemia 
occurred, and each time 500 ml of the 27.9% calcium perfusion was administered. A 250 mL 
volume of propylene glycolic acid was given orally twice a day, together with artificial 
rumen flora (Rumin®, Kela Laboratoria) during 10 days. Food (hay, silage) and water were 
continuously available. The animal rose for the first time 7 days after admission and had a 
moderate appetite, although diarrhoea persisted. Leukocyte counts on day 11 (2.9 x 109 /L, 
reference interval: 6.0-9.0x109 /L) and day 16 (12.5 x 109 /L) showed a gradual recovery of 
the leucopenia to a normal level. On day 19 after admission the animal was recumbent but 
alert. Episodes of lateral decubitus and depression occurred and the animal was euthanized on 
ethical and economic grounds.  
Pathology 
 Due to financial restraints, the post-mortem examination was limited to a macroscopic 
investigation of the intestines. The results were moderate colitis and proctitis.  
Herd check and additional investigations at the herd level 
 Immediately after the detection of BVDV, the veterinary surgeon sent a bulk milk sample 
to the laboratory, as well as whole blood collected in ethylenediamine tetra-acetic acid 
(EDTA) from all non-lactating cattle older than 6 months. With a view to cutting costs, 400 
μL of each individual blood sample were assembled in pools to a maximum of 30 samples 
per pool. Both bulk milk blood pools were investigated using RT-PCR tests, which all gave a 
negative result.   
As the herdsman was reluctant to pay for more analyses, further investigations of the 
young calves were postponed until July 17, 2009. On that day, blood samples for virus 
detection were collected from all young animals not tested before. Two animals were RT-
PCR positive, one of which was 3 weeks old at the time of sampling. The other was 1 year 
old and had been 3 months old when the health problems started among the cows. Of 17 
young cattle tested for the presence of BVDV antibodies, only the 2 RT-PCR positive ones 
were seronegative. Three weeks later the 2 were still viraemic as shown by a repeated 
antigen-ELISA. This indicated that these calves were persistently infected. 
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The PCR amplification and sequencing of part of the 5’UTR were performed as described 
previously (Letellier et al., 1999) to determine the genetic type of BVDV involved. The 
sequence was aligned with other BVDV1 sequences from Belgian viruses, or retrieved from 
databases. Multiple sequence alignments were generated with the programme CLUSTALX 
(Thompson et al., 1997). Evolutionary distances between sequences were estimated using the 
Kimura-2 parameter method. Phylogenetic analyses were conducted by using the Neighbor-
Joining algorithm of the MEGA version 4 software (Tamura et al., 2001). The phylogenetic 
analysis showed that the virus clustered within the BVDV1b subgroup, which represents the 
major subgroup in Belgium (Couvreur et al., 2002). 
Discussion 
The differential diagnosis of haemorrhagic diarrhoea in adult cattle is limited. Coccidiosis 
commonly occurs between the age of 3 months and 2 years and rarely in younger or older 
cattle. Moreover, the mortality rate due to Eimeria infection tends to be low. Clostridium 
perfringens can cause acute haemorrhagic enteritis and is an important problem in both 
youngsters (enterotoxemia) and high yielding dairy cows (haemorrhagic bowel syndrome) 
(Dennison et al., 2002). Without the typical lesions (enterotoxemia or haemorrhagic bowel), 
the isolation of even a high amount of Clostridium perfringens in the faeces, is still of an 
unknown significance (Abutarbush and Radostits, 2005). As a result, it cannot be excluded 
that Clostridia enterotoxemia played a secondary role in this case of haemorrhagic colitis and 
rectitis. 
Although coronavirus infection causes mild symptoms in adult cattle, occurrences of 
severe outbreaks have been reported (Decaro et al., 2007). However, spreading of 
haemorrhagic diarrhoea to all cows within the herd in a single day, absence of mortality, and 
inclusion of heifers and some of the calves, all signs characteristic of coronavirus infection, 
were absent in the present case.  
Malignant catharral fever (MCF), a disease occurring rarely in our area, can cause 
leucopenia and haemorrhagic diarrhoea (Pardon et al., 2009). Haemorrhagic diarrhoea is 
mainly seen with the alimentary and peracute form of MCF. The proximity of sheep is the 
essential factor for the development of MCF and no sheep were present on the farm or 
adjacent pastures. Moreover, at least one of the other sick cows should have shown other 
signs of MCF, such as stomatitis, kerato-conjunctivitis or nervous disorders. Ingestion of a 
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large quantity of acorns may provoke haemorrhagic diarrhoea, but no oak trees were found in 
the immediate environment. 
Salmonellosis and BVDV infection are the most important differential diagnoses of 
diarrhoea in combination with severe leucopenia. Leucopenia is frequently noticed in cases of 
transient BVDV infection in cattle (Bolin and Grooms, 2004; Müller-Doblies et al., 2004) 
and has been reported as one of the symptoms in severe outbreaks of BVDV infection (David 
et al., 1994; Ridpath et al., 2006). Considering the absence of leukocytes in our case, the 
BVDV viraemia only in the initial stage of illness, and the seroconversion, it can be 
concluded that the cow mentioned underwent a transient BVDV infection. Persistently 
infected (PI) cattle do not produce antibodies against the BVDV strain that infects them 
persistently. Conversely, they will have a humeral response after postnatal superinfection 
with a non-related, antigenically different isolate (Kapil et al., 2005). In our case paired sera 
revealed seroconversion to the BVDV and transient viraemia, indicating that the infection 
was postnatal. The interval between the positive and the subsequent virus negative blood 
sample was only 10 days, but this is not indicative for the duration of viraemia, as the animal 
was already ill for several days and may have been infected even earlier.  
Although postnatal BVDV infection increases the risk of severe symptoms in Salmonella-
infected cattle (Daly and Neiger, 2008), neither seroconversion to the 2 most common 
Salmonella types present in our region, nor Salmonella culture revealed an involvement of 
salmonellosis in this case. Other possible causes of haemorrhagic diarrhoea are not likely 
because of the age of the cows affected and the distribution of sick animals in the herd. So it 
is likely that that the transient BVDV infection was responsible for the severe symptoms. 
Nevertheless, we regret not having sampled the cow for infection with coccidia, because 
immunosuppression by a transient BVDV infection could trigger a subclinical Eimeria 
infection to become clinical, even in adult cattle.  
Fatal postnatal BVDV infection in adult cows has been described before (David et al., 
1994; Carman et al., 1998; Amiridis et al., 2004). Diarrhoea is a constant symptom in all 
these cases, but none of these articles states a combination of mortality and faeces containing 
massive amounts of blood in adult cows, although dysentery and blood-tinged faeces are 
mentioned by David et al. (1994). Furthermore, the cow in our case did not show any 
ulceration of the buccal mucosa, which is in contrast with the cases of Amaridis et al. (2004), 
Carman et al. (1998) and one of the 3 cases described by David et al. (1994), in which 
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erosions were noticed in about half the affected cows. Others have reported abortion among 
the clinical signs, but this was not noticed in the anamnesis of our case (Carman et al., 1998; 
Amiridis et al., 2004; Muskens et al., 2004). The combination of haemorrhagic diarrhoea and 
pneumonia as seen in affected herdmates of the animal described is a common finding in 
other reports of severe BVDV outbreaks (Amiridis et al., 2004; Carman et al., 1998). The 
absence of abortion in our case emphasizes once more the variability of BVD 
symptomatology.  
 Whereas type 2 BVDV is predominant in severe outbreaks of postnatal infection, this 
report shows that also type 1 virus is capable to provoke severe disease as reported earlier 
(Amiridis et al., 2004; Vilcek et al., 2005). Interestingly, in the present case only 
periparturient cows were affected. As there is physiological immunosuppression around 
parturition (Cai et al., 1994; Hoeben et al., 2000), the extreme leucopenia might have been 
the consequence of a complementary effect of this phenomenon and BVDV infection. All 
peripartum cows and calves under 6 months were housed in adjacent boxes, which made full 
contact between these cows and PI animals likely.   
As PI animals are by far the most important source of infection with BVDV (Lindberg 
and Houe, 2005), the scenario of infection by a PI bovine is the most likely one in this case. 
At the age of 3 months, when the cows started to show severe symptoms, the older of the 2 PI 
calves detected, was housed in a straw box adjacent to the cow’s calving pen. The PI and the 
cows were only fenced off by vertical bars (Figure 1) and it is very likely that this PI had 
infected the periparturient cows. Although virus excretion may be partially suppressed by the 
presence of colostral antibodies, this phenomenon may only hold until 3 months after birth, 
since the influence of colostral antibodies diminishes considerably from that age on (Zimmer 
et al., 2004).  
The PI calf must have been in close contact with the periparturient cows for 2 months 
after the last symptoms disappeared, because the herdsman usually removes the calves to 
another stable at the age of 5 months. Further infection of postpartum cows may have been 
prevented because these cows were immune before entering the calving pen. They could have 
been infected with a lower amount of BVDV, for instance by contact with the sick cows or 
other transiently infected cattle, or by personnel transferring the virus. The lower infection 
dose may be responsible for obvious symptoms failing to appear (Walz et al., 2001).   
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The question remains how the BVDV infection entered the herd. The anamnesis revealed 
that during the final months of 2007 and early in 2008, severe BVDV-related problems had 
afflicted the cattle of the herdsman’s sister and a forklift truck had been used to muck out 
stables on both farms. Although direct contact between cattle of the 2 herds never took place, 
this is a possible source of infection, as farm staff and commonly used equipment can transfer 
the virus to another farm (Ståhl et al., 2005).  
The serious symptoms after exposure of the herd to a PI animal (Larson, 2005), and the 
history of an infection route via personnel or equipment indicate a first infection of a naïve 
herd. If routine BVDV monitoring had been conducted on this farm, the stockbreeder may 
have been aware of his vulnerable situation before the severe disease occurred. A monitoring 
test such as the one performed semi-annually in the Dutch voluntary BVDV control 
programme would have raised the alarm, as it consists of a combination of a young stock 
serological spot test and a bulk milk test for detection of both BVDV-antibodies and virus. 
The BVDV must have been circulating on the farm for 8 months at least before the severe 
cases and deaths occurred, given the age of the oldest PI animal (3 months) at the time of the 
outbreak of haemorrhagic diarrhoea in the cows. 
Finally, at necropsy the colitis and proctitis were only mild, which may indicate recovery 
of the intestine after 19 days of illness. Despite this potential sign of recovery, the permanent 
recumbence, probably caused by progressive weakening and exhaustion, prompted us to opt 
for euthanasia.    
Conclusions 
In view of the transient BVDV detection by RT-PCR, seroconversion to BVDV and 
resemblance of the clinical signs with those reported in other cases of severe postnatal BVDV 
infection, it is very likely that the case described was a postnatal BVDV infection with 
symptoms more severe than usual. Furthermore the case shows that severe disease by BVDV 
infection is not always caused by a type 2 strain. This conclusion emphasizes the complex 
symptomatology of primary, transient BVDV infection, going from subclinical course to life 
threatening disease. Therefore, regular monitoring for BVDV seems necessary, and should be 
implemented as an elemental part of herd health management programmes. The clinical 
presentations are far too numerous and non-specific to ascertain early detection of the 
infection by its clinical manifestations alone.  
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Abstract 
The purpose of this study was to investigate the statistical association between herd 
Bovine viral diarrhoea (BVD) status based on bulk milk antibody detection and monthly Bulk 
Milk Somatic Cell Count (BMSCC) as a reflection of the udder health. A distinction was 
made between vaccinating and non-vaccinating herds via a questionnaire concerning BVDV 
vaccination. No significant difference in BMSCC was found between vaccinating (228,300 
cells/ml; SD 180,019) and non-vaccinating (237,070 cells/ml; SD 77,900) herds. Non-
vaccinating herds (n=243) were selected, and the relationship between a single BVDV 
antibody optical density ratio (OD ratio) and the BMSCC of each herd over a 12 month 
observation period evaluated. For this purpose, the non-vaccinating herds were divided into 
five groups depending on bulk milk BVDV-antibody OD ratio. Overall, no significant 
relationship between the antibody OD ratio and the BMSCC was found. Still, when 
comparing the category with the lowest OD ratio (essentially BVDV naïve herds; 
BMSCC=211,390 cells/ml) with the combined four other categories (BMSCC=242,790 
cells/ml), a significant difference in BMSSC was observed (P=0.01). 
Keywords: viral diarrhoea virus; bulk tank milk test; somatic cell counts 
Introduction 
Mastitis is currently one of the most important health problems in cattle and the cause of 
considerable economic losses to the dairy industry (Bradley, 2002). As the BMSCC is a 
proxy for measuring the prevalence of subclinical mastitis, it is commonly acknowledged as a 
criterion for estimating the udder health status of a herd (Schukken et al., 2003). 
BVD virus (BVDV) is a pestivirus affecting cattle world-wide and is likely to remain 
endemic in absence of systematic control measures (Lindberg and Alenius, 1999). Cattle can 
be infected persistently or transiently. Whilst transient infection with BVDV may go 
unnoticed, it does cause decreased fertility and immunosuppression (Lindberg and Houe, 
2005). Moreover, cattle suffering from a transient BVD infection are more susceptible to 
other infections by synergy of the BVDV in co-infections (Ridpath, 2010).  
A relation between BVDV infection and the severity of concurrent infections with other 
pathogens has been documented previously (Fulton et al., 2000; Kelling et al., 2002; 
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Gånheim et al., 2003; Daly and Neiger, 2008; Diéguez et al., 2009). As a result, the defence 
mechanisms of the mammary gland are also supposed to be adversely influenced by the 
immunosuppression associated with acute BVDV infection. Although this issue has 
previously been investigated under field conditions, the results regarding the impact on 
BMSCC were contradictory (Niskanen et al., 1995; Waage, 2000; Beaudeau et al., 2005; 
Berends et al., 2008). The aim of the present study is to gain insight into the association 
between BVD status and BMSCC by excluding the influence of vaccination and classifying 
herds in groups, based on bulk milk BVDV-antibody optical density ratios. Highlighting the 
relationship between BVD and udder health may contribute to alerting stakeholders to the 
economic consequences of the disease. 
Materials and methods 
Bulk milk sampling and testing 
In 2009, the mean size of Flemish dairy herds was 57 lactating cows, with a yearly 
production of approximately 400,000 litres per herd (Ryckaert et al., 2009). At each milk 
collection in Flanders a bulk milk sample is taken on the farm by an automatic sampling 
device mounted on the tanker. The samples are stored at a temperature between zero and four 
°C, without any preservative until arrival at the Milk Control Centre Flanders (MCC, Lier, 
Belgium). All samples are analysed for composition and presence of antibiotic residues. Four 
samples a month are randomly selected for BMSCC analysis and two for the microbiological 
quality. Samples are analysed the day after collection. Through this automated sampling 
procedure samples from 500 herds were randomly selected from a total of 2700 dairy herds in 
Flanders. These were then tested for BVDV-antibody OD ratios using the IDEXX 
HerdCheck BVDV Ab ELISA (IDEXX Europe, Hoofddorp, The Netherlands). Herd 
selection was stratified by region and all sampling was performed between 23rd and 25th 
August 2009. Samples were frozen at -18°C and the sample-to-positive (S/P) ratios of 
BVDV-antibodies determined for 457/500 herds on 31st August 2009. BMSCC was 
determined by a Fossomatic FC appliance (Foss Benelux, IJsselstein, The Netherlands) and 
monthly values calculated as the arithmetic mean of 4 samplings a month. These were 
collected from the Milk Control Centre (MCC) records for the six months preceding the 
antibody test-day and for a further six months after that point.  
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Questionnaire 
All 457 farmers were sent a letter to ask for their cooperation in the study. In an 
accompanying letter they were asked five questions about BVD vaccination of their herds. 
The majority replied by e-mail. Farmers who were willing to cooperate, but did not have 
answered the questionnaire were contacted by phone to obtain this information. The 
following questions were asked: “Have your milking cows and heifers ever been vaccinated 
for BVD, and if so, please indicate the name of the vaccine used?” Secondly, “What is the 
approximate date (month and year) of the last vaccination?”, and finally “Do you routinely 
vaccinate dairy young stock for BVD? If so, please mention the name of the vaccine”. All 
questionnaires were completed within three months after milk sampling for BVDV-
antibodies. 
Statistical analysis 
The data were analysed using a linear mixed effect model with herd as repeated effect, 
antibody OD ratios as either a continuous or categorical independent variable and monthly 
BMSCC as the outcome variable. An autoregressive correlation structure of the first order 
was used to model the correlation structure. In all models month was taken into account as 
co-variable to correct for the seasonal effect. Normal probability plots of residuals and plots 
of residuals versus predicted values were generated to check whether the assumptions of 
normality and homogeneity of variance had been fulfilled. No problems were detected. For 
all linear mixed models, the goodness of fit measures included −2 x log likelihood (−2LL), 
Akaike’s information criterion (AIC), and Bayesian information criterion (BIC). All fixed 
effect covariates and relevant first order interactions were evaluated and included in the 
model when statistically significant (P < 0.05). All analyses were performed in Spotfire S+ 
8.2 (TIBCO software, USA). 
First the entire dataset (both vaccinating and non-vaccinating herds) was analysed to 
determine the effect of the herd vaccination status on the BMSCC and BVDV-antibody OD 
ratios, respectively. In the model with BMSCC as outcome variable, vaccination status at the 
herd level (2 levels; vaccinated versus non-vaccinated), BVDV-antibody OD ratio [5 levels; 
(1) essentially naïve (S/P < 0.25), (2) low antibody (S/P 0.25 to < 0.50), (3) mid-range (S/P 
0.50 to <0.75), (4) high antibody (S/P 0.75 to < 1.00), and (5) actively or recently infected 
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herds (S/P ≥ 1.00)] and the interaction term between both variables were included as 
categorical independent variables.  
Subsequently, only the 243 non-vaccinating herds were selected, to exclude the influence 
of vaccination induced antibodies on the OD ratio. The effect of the BVDV-antibody OD 
ratio on the BMSCC was analysed in a continuous manner and also by categorising the 
antibody OD ratios into the five categories. Furthermore, the total number of cattle present on 
the farm was included as a co-variable to correct for potential influence of herd size. To 
evaluate the proportion of variance in BMSCC occurring at the herd and observation level of 
the data hierarchy, a two-level null model was used with herd as random effect. 
Results 
Vaccinating and non-vaccinating herds 
In total 406 (88.8%) of the 457 questioned herd owners answered the questionnaire. 
Ninety of these 406 (22.2%) declared that their dairy cows and heifers were vaccinated for 
BVDV, while 243 (59.9%) did not vaccinate the lactating cattle. The answers of the 
remaining 73 farmers were not reliable enough to be used in the study, since they did not 
know the vaccine name and, as a result, their answers about BVDV vaccination appeared to 
be uncertain, or herd size numbers were missing. The average BMSCC was 223,728 cells/ml 
(SD 74,082) for vaccinating herds and 238,582 cells/ml (SD 73,044) for non-vaccinating 
herds (Table 1). No significant difference in BMSCC was present between vaccinating and 
non-vaccinating herds (P=0.41). BVDV vaccinating herds had significantly higher OD ratios 
for BVDV-antibodies as compared with non-vaccinating herds (0.93 and 0.71 respectively; 
P<0.01). Further analysis revealed that the influence of the vaccination status on the BMSCC 
was dependant on the category of BVDV-antibody OD ratio (P < 0.05). Herds with the 
lowest OD ratio (< 0.25) had a significantly lower BMSCC (192,300; SD 101,302) compared 
to herds belonging to group 2 (278,540; SD 112,112), group 4 (235,080; SD 89,757) or group 
5 (236,370; SD 67,370) (P < 0.01). The difference between groups 1 and 3 was not 
significant (221,140; SD 80,416). The four groups with OD ratios over 0.25 also differed in 
BMSCC among themselves, even after correcting for multiple comparisons. 
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vaccination status min. first 
quartile 
median third 
quartile 
max. mean standard 
deviation 
BMSCC            
   non-vaccinating 66,000 186,000 235,000 288,000 553,000 238,582 73,044 
      vaccinating  50,000 168,000 217,000 272,000 480,000 223,728 74,082 
BVDV OD ratio        
       non-vaccinating 0 0.49 0.75 0.97 1.53 0.71 0.33 
       vaccinating 0.2 0.67 1.01 1.20 1.59 0.93 0.33 
 
Table 1. Descriptive statistics for BMSCC and BVDV-antibody OD ratios stratified by 
vaccination status. 
 
Non-vaccinating herds 
Of the 243 non-vaccinating herds 11.3% were classified in group one, the essentially 
BVDV-naïve group, while 14.9%, 23,1%, 29.1%, and 21.4% belonged to groups 2, 2, 4, and 
5, respectively.   
For the non-vaccinating herds, when treating the antibody titre as either a continuous or 
categorical variable divided in 5 categories, no significant relationship between the OD ratio 
and the BMSCC could be determined (P=0.13) (cat. 1: BMSCC=211,390; cat. 2: 
BMSCC=238,140; cat. 3: BMSCC=242,920; cat. 4: BMSCC=247,350; cat 5: 
BMSCC=242,750 cells/ml). However, when comparing the category with the lowest OD 
ratio (essentially BVDV-naïve herds; S/P<0.25; BMSCC=211,390 cells/ml) with the 
combined four other categories (243,510 cells/ml) a significant difference was observed (P < 
0.01). The highest variation in BMSCC resided at the observation level (99.9%). Month and 
BVDV-antibody OD ratio explained 3.7% of the variation in BMSCC.  
Discussion 
As the budget was limited, a single BVDV test was used in conjunction with multiple 
BMSCC testing time points. The use of bulk tank milk antibody values to estimate the BVDV 
seroprevalence in a herd is well established (Niskanen et al., 1991, Niskanen, 1993; Paton et 
al., 1998; Beaudeau et al., 2001). Moreover, for non-vaccinating herds, the level of BVDV-
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antibody values in bulk tank milk corresponds with the infection status of the herd, because 
PI animals are most likely to be found in herds with the highest serological prevalence (Ståhl 
et al., 2002; Houe, 2005; Houe et al., 2006). As a result, herds with a current infection will 
have high levels of antibodies to BVDV in their bulk milk (Niskanen et al., 1991; Drew et al., 
1999). The same applies to recently recovered herds, due to the presence of long lasting 
antibodies in previously infected animals (Houe, 1999). Consequently, the antibody level in 
bulk tank milk is expected to gradually decrease to low or undetectable levels within a period 
of three to four years (Lindberg and Alenius, 1999). Therefore, we assumed that one BVDV-
antibody sample was representative for the long-term herd BVDV status. A carry-over effect 
of BVDV infection on BMSCC has also been proposed, which may result in an increased 
BMSCC until up to one year after BVDV eradication (Waage, 2000; Beaudeau et al., 2005). 
The result is that in herds recently cleared of BVDV, both the BVDV antibody quantity and 
the BMSCC may stay high during one year at least.  
In contrast to the single BVDV-antibody test, monthly BMSCCs from six months before 
until six months after the antibody test-day were used, because an accurate image of chronic 
mastitis can only be obtained by frequent sampling (Lievaart et al., 2011). If BVDV was 
circulating in a herd, one would temporarily expect more sick cows and cows under antibiotic 
treatment. This could result in short term BMSCC variations since the milk from these 
animals should not be collected in the bulk tank.  
As the effect of the vaccination status on BMSCC seemed to depend on BVDV-antibody 
OD raio, using the non-vaccinating herds only appeared to be a well-considered choice for 
investigating differences between the groups. The non-vaccinating herds of group one, 
considered BVDV-free, had significantly lower BMSCC values compared with the combined 
groups of BVDV infected herds. The fact that no significant differences in BMSCC were 
found among the four BVDV-antibody positive groups when only considering the non-
vaccinating herds might suggest that a positive or negative result for bulk milk BVDV-
antibodies is useful to distinguish BVDV infected from free herds. On the other hand, it 
indicates that the degree of BVDV infection cannot be measured by differences in BVDV-
antibody OD ratios in non-vaccinating herds. 
Although the immunosuppression accompanying transient BVDV infections forms a 
potential explanation for the lower BMSCC in BVDV-naïve herds, it is common knowledge 
that the farmers’ management skills have an important effect on udder health (Dufour et al., 
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2011). Moreover, although performed with cow-calf herds, a Scottish study showed that 
maintaining a herd free of BVDV contributes indirectly to both the farm income and its risk 
management through its effect on the management of the whole farm (Stott et al., 2003). In 
this regard, the positive association between BVDV-antibody titre and BMSCC could be 
attributed to some other herd level management practices related to the milking technique, 
milking equipment, and environmental hygiene. Unfortunately, because of privacy matters, 
more management factors could not be included in the present study. Still, including herd as a 
repeated effect as was performed in this study takes into account the association between 
observations within the same herd, and thus controls for any confounding factor at the herd 
level (Dohoo et al., 2003). Also, the high response rate on the questionnaire limited the 
probability of response bias. 
Conclusion 
The results of the present study suggest that dairy herds have lower BMSCCs in absence 
of BVDV infection.  
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Abstract 
Bovine viral diarrhoea virus (BVDV) is one of the most important viruses to cause 
disease in cattle worldwide. The virus is endemically present in Belgium. Clinical diagnosis 
of BVDV infection is difficult. Therefore, monitoring through testing is necessary to detect 
the presence of the virus on farms. As vaccination alone does not suffice for eradication, a 
combination of measures is required for successful control. Via a questionnaire, the BVDV 
policy on 241 selected Flemish cattle farms was investigated and this revealed some striking 
results. For the majority of herds, the BVDV status was unknown (63%) and only 23% had a 
monitoring programme in place. Furthermore, on 71% BVDV vaccinating farms vaccination 
against BVDV was implemented as a strategy, without knowing the actual BVDV status.  
 
Introduction  
Bovine viral diarrhoea (BVD) is an infectious disease of cattle with a worldwide 
distribution (Ridpath, 2010a), causing significant economic losses (Houe, 1999; Fourichon et 
al., 2005). Infections can be either persistent or transient. Persistently infected (PI) cattle are 
key in spreading and maintaining the infection within and between herds, as they 
continuously shed large amounts of BVD virus (BVDV) during their entire lives (Lindberg 
and Houe, 2005; Fulton et al., 2009). Therefore, most transient infections are caused by direct 
contact with PI cattle. The direct consequences of transient BVDV infection may vary from 
subclinical or mild disease to acute outbreaks with severe disease and high mortality. 
Moreover, transiently infected (TI) cattle may suffer from immunosuppression, which makes 
them more susceptible to secondary infections (Brackenbury et al., 2003; Ridpath, 2010b; 
Chase, 2013). Between herds and animals, substantial differences in clinical presentation of 
BVDV infection have been noticed. This variability has been attributed to herds/animals 
having different immune statuses (Lindberg, 2003), or differences in strain virulence (Bolin 
and Ridpath, 1992; Pellerin et al, 1994; Baule et al., 2001; Walz et al., 2001; Kelling et al., 
2002). Because of the marked variation in clinical presentation it is usually difficult to detect 
the presence of a BVDV infection in a herd by its clinical presentation alone (Lindberg and 
Alenius, 1999; Ridpath, 2003; Evermann and Barrington, 2005). As a result, monitoring by 
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diagnostic testing for presence of BVDV is vital to determine herd status and for effective 
BVDV control.  
In the absence of a nationwide eradication programme in Belgium, control is typically 
performed at the herd level by decision of the farmer. Meticulous tracing, correct 
administration (Laureyns et al., 2010), and implementation of the key principles of BVDV 
control as stated by Lindberg and Houe (2005) are essential to successfully control BVDV at 
the herd level. These principles are: stringent biosecurity, detection and removal of PI cattle, 
continuous monitoring, and potential implementation of vaccination. As the prevalence of 
BVDV infection at the farm level is high in Belgium (Sarrazin et al., 2013), biosecurity 
measures are highly important to protect herds against BVDV (re-)infection. Therefore, 
implementation of biosecurity measures has to be the first step in BVDV control in Belgium. 
Most importantly, PI animals should be removed from the herd, as they play the key role in 
the transmission of BVDV by continuous shedding of infectious virus (Lindberg and Houe, 
2005). In BVDV-free herds, longitudinal surveillance should be combined with biosecurity 
enhancements to detect and prevent potential (re-)infection and allow prompt action in the 
event of disease incursion. Monitoring can be performed using serological spot tests (Houe, 
1994; Booth and Brownlie, 2012) and has to be continued as long as BVDV is present in the 
region. Although not 100% effective in protecting every individual animal, vaccination can 
be an essential component of a herd level control programme (Ridpath, 2012). However, if 
eradication is to be achieved, vaccination must be combined with the other three principles of 
BVDV control (Lindberg and Houe, 2005; Rodning et al., 2010; Booth and Brownlie, 2012).  
Although it has been emphasized in many publications that BVDV control requires a 
combination of different, strictly executed measures, little information is available on how 
these recommendations are implemented in the field. This study highlights the BVDV 
management on Flemish farms. 
 
Material and methods 
During 2011, a large multicentre study was conducted (Pfeiffer et al., 2012) to identify 
calf-level factors associated with Bovine Neonatal Pancytopenia (BNP) on BNP-affected 
farms (Jones et al., 2013), and herd-level factors that explained why some farms experienced 
cases of BNP and others did not (Sauter-Louis et al., 2013). Since BNP is hypothesised to be 
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associated with BVDV vaccination, a substantial part of the interview was on BVDV 
management. Questions of relevance for the present study were selected from the BNP 
questionnaire and are presented in Table 1.  
The Belgian contribution only took place in the Flemish speaking part of the country, 
Flanders, and was conducted by the Faculty of Veterinary Medicine of Ghent University in 
cooperation with the Flemish Animal Health Organisation “Dierengezondheidszorg 
Vlaanderen” (DGZ). Through a call on the website of DGZ and notifications in veterinary 
and farmer magazines, veterinarians and farmers were encouraged to report suspected BNP 
cases. Case farms were visited for sample collection, and a questionnaire was used to 
interview the farmers on colostrum feeding, cattle health management, disease management, 
and medication use. Farms where the veterinarian had reported a suspicion of BNP were 
classified as case farms. The control farms belonged to the clientele of the same veterinary 
practice and had never been diagnosed with BNP before. They were of the same type and 
approximately the same size as the corresponding case farm. Farmers of the control farms 
were interviewed by telephone, using the same questionnaire. All managers of the case and 
control farms were interviewed by the first author. Data from 241 Flemish farms was 
available for the study. 
 Recognition of BVDV infection by its clinical presentation alone is very difficult if not 
impossible. Therefore, in this study a herd was only considered BVDV-free if the status was 
based on a test-and-cull’ programme or a ‘herd test’. A test-and-cull programme consists of 
virological testing by PCR or antigen-ELISA of all cattle in the herd followed by culling of 
PI animals.  
In the present study, continuous testing of all newborns by antigen-ELISA for already 
more than one year, or regular serological spot tests of which the last one took place within 
the last 12 months, were both accepted as a herd test. The intention of using a spot test is to 
detect BVDV circulation in a herd by testing five to ten blood samples of young stock 
between 8 and 12 months old for the presence of BVDV antibodies (Houe, 1992). 
Results 
The results are summarised in Table 2. Farmers were asked ‘Was the herd BVDV-free for 
the last 12 months?’. Of the 241 herds, 82 had a known BVDV status that was based on 
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testing; 66 of those 82 had been BVDV-free and 16 had been BVDV infected during the past 
year. On 158 of the farms (66%) there had been no monitoring for BVDV. When the farmers 
of the herds that were BVDV-free were asked for how long they had held this status, 11 of 
the herd managers communicated a date within the last 12 months, although they scored their 
herd BVDV-free for the whole of the preceding 12 months in another answer.  
 
 
Question Possible Answer 
  
Production type mixed  
dairy   
beef 
Veterinarian  code number 
Total number of cattle at time of the   
interview (young stock included)  
Vaccinations within the last 12 
months:  BVDV 
 
 
calves up to 6 months           name of vaccine 
young stock > 6m                 name of vaccine 
breeding heifers                    name of vaccine 
mature cows                          name of vaccine 
Was the herd BVDV-free during the 
last 12 months? 
yes - indicate date since when BVD free 
no 
unknown 
If BVDV-free, how has this been 
determined? 
control program  
test and cull  
herd test  
Have you had a confirmed BVDV 
animal (PI) on your farm within the 
last 12 months? 
yes 
no  
not monitoring for PI 
 
Was there a BVDV vaccination 
program? 
yes 
no  
 
Reason for starting vaccination: 
         
 
had a BVDV problem on farm 
to prevent the farm from having a  
BVDV problem               
unknown status 
others  
Currently still vaccinating against 
BVDV? 
yes 
no 
 
Which BVDV vaccine is currently 
used? 
 
 
 
Table 1. Questions of the bovine neonatal pancytopenia questionnaire selected for the present 
study. 
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On 55 (67%) of the 82 herds with known BVDV status (infected and free farms), BVDV 
testing consisted of a herd test while on the other 27 a test-and-cull method was in use.  
On the question ‘Have you had a confirmed PI animal on your farm within the last 12 
months?’ twenty of the 241 herd managers gave a positive answer (8%), whereas the majority 
(153) did not know whether a PI animal had been on the farm or not, as they declared that a 
monitoring programme for BVDV had not been in place (63.5%). On 68 (28%) of the herds 
the BVDV status was known, but no PI animals had been detected within the last 12 months.  
On 155 (64.5%) of the 241 farms, a  BVDV vaccination programme had been in us 
during the past 12 months or earlier. When asked for the ‘Reason for starting this 
vaccination’, there was one blank result and 83 of the 155 herd managers (53.5% of all 
vaccinating herds) answered that a vaccination strategy had been started because of a BVDV 
problem; 55 (35.5% of all vaccinating herds) had started the vaccination to prevent BVDV 
problems. When examining the names of BVDV vaccines used in the different age 
categories, it appeared that on 42 of the 155 vaccinating herds, only young stock under six 
months of age were vaccinated, all with a trivalent vaccine containing a BVDV component 
(Rispoval®3-BRSV-Pi3-BVD, Pfizer Animal Health). Of these 42 herd managers, only 16 
declared that the reason for applying Rispoval®3-BRSV-Pi3-BVD vaccination had been 
prevention of respiratory disease. On 93 farms vaccination of heifers and/or adults was still 
continued at the time of the interview (farms that only vaccinated young stock were 
excluded); 66 of these 93 (71%) herd managers did not know the BVDV status of their herd.  
Of the 20 herds where a PI animal had been found within the previous 12 months, 7 
applied BVDV vaccination of adult cattle at the time of the interview. Of these 7 herds, 5 had 
been vaccinated for two years or longer. 
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  Herd type   
 
 
 
Dairy Beef Mixed Overall 
Herd information (n=241) 
 
    
Number of herds  113 72 56 241 
Number of veterinary practices 
involved 
     
43 
Average number of animals per herd  142 (46-
450) 
131 (4-
380) 
192 (50-
530) 
150 (4-530) 
Questions on knowledge of BVDV 
status 
    
1. Was the herd BVDV-free during 
the last 12 months? 
    
          Answer                 yes 27 22 17 66  (27%) 
           no 8 3 5 16  (7%) 
           unknown 78 46 34 158 (66%) 
           no answer    1 
Herds with known BVDV status 35 25 22 82 (34%) 
     
2. If BVDV-free, on what basis is this  
determined? 
    
               test and cull program 11 9 7 27/82 
(33%) 
               herd test (monitoring) 24 17 14 55/82 
(67%) 
3.Had a PI within the last 12 months     
               yes 10 5 6 20 (8.5%) 
               no 28 22 18 68 (28%) 
               not monitoring for BVDV 75 46 32 153  
(63.5%) 
4. Had a vaccination program during 
last 5 years? 
    
           yes 63 48 44 155 
(64.5%) 
           no 50 23 12 85 (35%) 
           no answer    1 
     
SUBSET OF DATA: BVD 
vaccinating herds (n=155) 
    
     
Vaccination only of cattle <1y     42 (27%) 
Reason for starting vaccination     
           had a BVDV problem in herd 37 26 20 83 (53.5%)   
           to prevent BVDV problems 24 13 18 55 (35.5%) 
           others 2 9 5 16 (10.5%)   
           no answer     1  
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SUBSET OF DATA : herds still BVD 
vaccinating at the time of the 
interview (n=93) 
 
    
Still vaccinating adult cattle  
Still vaccinating adult cattle and  
                 BVDV status unknown   
   93  
 
66 (71%)  
     
 
Table 2. Descriptive data on some aspects of bovine viral diarrhoea (BVDV) management on 
241 Flemish dairy and beef herds 
 
 
Discussion 
The main objective of this study was to investigate BVDV management on selected farms 
by describing common policies for PI animal detection and monitoring, two of the three 
essential BVDV control measures. The results were collected as part of a larger case-control 
study on the identification of risk factors for the occurrence of BNP, a BVDV vaccination 
related disease (Jones et al., 2013; Sauter-Louis-et al., 2013).  
The fact that all questions for this study were asked by the same person, both on case and 
control farms, reduced the likelihood of information bias. Although the same questionnaire 
was used for both case and control farms, the interviews occurred face to face on case farms, 
whereas they were conducted by telephone on control farms. Therefore, the answers collected 
on case farms might be considered more reliable, as they were better supported by written or 
electronically stored data such as laboratory results provided by the farmer at the herd visit.  
Two different descriptions of the same question indicated that the BVDV status was 
unknown on 66% (n=158) and 63.5% (n=153) of the farms during the past year, respectively 
referring to the absence of BVDV and presence of a PI animal. The fact that there was little 
difference between the figures obtained via both questions reinforces the certainty that the 
majority of the herd managers did not know the BVDV status of the herd. It is interesting to 
note that when asked if they knew their BVDV status, 16 farm managers answered that their 
herd had been infected in the last 12 months. Yet, when asked about the presence of PI 
animals, 20 farm managers stated that PI animals had been identified on their premises in the 
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last 12 months. Remarkably, four farmers did not appear to know that the presence of PI 
animals is an indicator of herd-level infection. Moreover, when asked for how long their 
herds had been BVD-free, 11 herd managers communicated a date within the last 12 months, 
although they had previously scored their herds BVDV-free for the whole of the preceding 12 
months. These examples demonstrate that a question may produce different answers when 
asked in a different way and illustrates potential difficulties when working with 
questionnaires. 
Interestingly, two veterinary practices of the 43 involved were responsible for 16 of the 
55 herds with BVDV surveillance. The latter result suggests that few veterinary practices 
implement BVDV monitoring in their herd health management programmes.  
Farms were not classified as BVDV-free if this status was obtained from clinical signs. 
The only methods accepted for defining the BVDV status were: a herd test, or a test-and-cull 
programme during the last year. Of the 82 herds with known BVDV status, those 27 where a 
test-and-cull programme had been used cannot necessarily be considered as herds with 
BVDV surveillance. On these farms the respective herd managers had performed one whole 
herd test for the presence of PI animals during the last year, reacting on a suspicion of BVDV 
infection, and afterwards assumed that herd had been BVDV-free since then. The only 
methods that can be considered as surveillance are regular serological spot tests or virological 
testing of all newborn calves on a whole blood sample from the age of two months on. Ear 
notch testing (Kuhne et al., 2005; Hill et al., 2007) can be an alternative, but was not yet 
available in Flanders at the time the study was conducted. It can be concluded that only 23% 
(n=55) of all herds had a BVDV surveillance programme in the strictest sense. Nevertheless, 
virological testing of all newborns as a sole monitoring measure might not rapidly identify re-
infection of the herd (Houe et al., 2006), for instance because of overlooking a PI calf due to 
an administrative failure (Laureyns et al., 2010), a false negative result (Presi et al., 2011; 
Fux and Wolf, 2012) in previous detection and removal of PI cattle, or external re-infection. 
It might take two years or more until a programme with virological testing of newborns as the 
only measure will detect a false negative PI animal, that is when its first calf will be 
virologically tested.  
The BNP case farms were all BVDV vaccinated and the corresponding controls were 
linked to the same veterinary practice. Therefore, it can be supposed that the veterinarians 
involved were conscious of the importance of BVDV infection, because they had advised 
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vaccination to their clients. On the other hand, it appeared that most of them did not apply all 
principles of BVDV control (Lindberg and Houe, 2005), as on 71% of those farms still 
vaccinating at the moment of the interview, the BVDV status was unknown. This raises the 
question as to whether the veterinary profession as a whole still has an over-reliance on 
BVDV vaccination for control of the disease, when it should be considered as only one part 
of a range of control measures that should be implemented.  
As the multi-country study was focused on BNP, a BVDV vaccination related disease, the 
number of vaccinating herds may have been overestimated. Most likely, the control group 
had been vaccinated as well, since it was recruited from the same veterinary practice as the 
case herds, and consequently, the same BVDV control strategy may have been implemented. 
On the other hand, at the time of the herd visit, most of the farmers had already been 
informed on BNP. Some had changed to another BVDV vaccine, whereas 20 of the original 
155 vaccinating herd managers had ceased vaccination at the time of the interview, most 
likely for fear of BNP. As a result, the figures are not suited to interpret the BVDV 
vaccination prevalence in Flanders. They rather show some shortcomings of vaccination 
management. Although vaccination on its own is not sufficient to eradicate BVDV from a 
herd (O’ Rourke, 2002; Booth and Brownlie, 2012; Ridpath, 2013), 66 of the 93 herd 
managers who were still vaccinating against BVDV at the time of the interview did not know 
the BVDV status of the herd (71%). Vaccination should be combined with all three necessary 
parts of BVDV control: biosecurity measures, detection and removal of PI animals, and 
monitoring (Lindberg and Houe, 2005). Moreover, the use and application of BVDV 
vaccines in the field is not always correct (Meadows, 2010). The present study shows that in 
almost one third of all vaccinating herds (27%; n=42) only young stock under six months of 
age had been vaccinated, while the advice is to reach a 100% coverage of the adult herd with 
the main objective of preventing infection of pregnant cattle (Lindberg and Houe, 2005).  
On 83 of the 155 vaccinating herds (53.5%), the decision of starting BVDV vaccination 
was made at the occurrence of a BVDV problem. Another 10% (n=16) of the herd managers 
did not really have the intention to control BVDV. They used a trivalent vaccine containing a 
BVD component, to protect calves from bovine respiratory disease (Rispoval®3-BRSV-Pi3-
BVD Pfizer Animal Health), but did not have a BVDV vaccination programme for older 
cattle. Not surprisingly, among these 16 there was only 1 dairy herd, because Belgian Blue 
cattle, the predominant beef breed in Belgium, are substantially more susceptible to 
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respiratory disease than dairy breeds (Bureau et al., 1999). Nevertheless, 42 farmers 
vaccinated only 3-month-old calves. Since only 16 stated that they vaccinated against 
respiratory disease, it can be assumed that 26 others considered vaccinating only 3-month-old 
calves as a herd level BVDV control strategy.  
Only 35.5% (n=55) of the vaccinating farmers stated to have started the vaccination 
programme to protect the herd from BVDV infection, without previous BVDV problems. 
Obviously, both these farmers and the ones who started vaccination after their herds had 
suffered from BVD problems (53.5%), hence the majority of vaccinating farmers, must have 
been aware of the economic consequences of BVDV infection.  
Finally, the observation that a PI animal was detected on five farms, despite BVDV 
vaccination during the last two years or longer, shows that continuous monitoring is 
necessary, even for herds where a BVDV vaccination scheme is running.  
 
Conclusion 
This study illustrates that even on selected farms, where many farmers were willing to 
vaccinate against BVDV and thus conscious of the impact of BVDV infection, the necessary 
elements of BVDV control were insufficiently implemented. In particular, too many control 
strategies were based on vaccination alone and only few herds were monitored for BVDV. 
These findings suggest that on many Flemish farms BVDV control remains incomplete and 
consequently inefficient, despite repeated communication and education from regional animal 
health services and the veterinary faculties. It is up to the veterinarians to train their clients to 
control BVDV efficiently.  
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Introduction 
The first part of the general discussion of this thesis is dedicated to the complexity of the 
disease. Although it is common knowledge that the clinical presentations of BVDV infection 
are too complex to allow for a reliable clinical diagnosis, many farmers and vets still expect 
to recognize presence of the BVDV by the clinical appearances. To address this 
misconception, an extraordinary early finding of cytopathic BVDV in an asymptomatic and 
very young calf and some exceptional clinical presentations are discussed, as well as the 
hidden effect of BVDV infection on udder health. 
An important aim of this doctoral thesis was to assess if the necessary elements for 
efficient BVDV control are implemented sufficiently in Belgium. Because clinical diagnosis 
is difficult, testing and continuous monitoring are essential to BVDV control. Unfortunately, 
it seems as if attempts to BVDV control or eradication in Belgium have not been efficient 
until now. The control schemes as recommended by the animal health services are adequate, 
but not meticulously executed in the field. Therefore, in the second part of the discussion 
recommendations will be provided for BVDV control at the herd level by listing points of 
attention for PI cattle detection.  
Finally, considerations are discussed, that might be of interest for the Belgian BVDV 
eradication programme that is currently being designed, by comparing the Belgian plan as set 
out at present with the ideal BVDV eradication strategy.  
Although the studies included in this thesis have been performed in Flanders, the 
conclusions can be extrapolated to the entire country, as the epidemiological situation is 
similar in Wallonia and Flanders. 
Complex pathogenesis and variety in clinical presentations of BVD  
The case report of Chapter 3.1 describes detection of cp BVDV in a 10-day-old calf 
without presence of ncp virus. As the calf showed no signs of MD, this was an extraordinary 
finding that highlights the complex pathogenesis of BVDV infection. Until now, cp BVDV 
was almost exclusively found in cattle shortly before or while they suffered from MD, and 
MD is only unarguably proven when cp and ncp BVDV are existing together in the same 
Chapter 6      General discussion 
126 
 
animal. It could not be determined if this exceptional cp BVDV infection also had an effect 
on the clinical appearance of the infection. Nevertheless, the observation that the 
haemorrhagic diarrhoea disappeared after treatment for Cryptosporidium, showed evidence of 
the clinical effects of co-infections and the way they can complicate the clinical outcomes of 
BVDV infection. Also in other cases, BVDV infection is often only one of the causes of 
disease. As usual, clinical diagnosis alone was not sufficient in the described case for 
detecting involvement of BVDV infection. 
Depending on the virulence of the BVDV strain (Bolin and Ridpath, 1992), the immune 
status of the host, reproductive status of the host, age of the host, and concurrent infections 
with other pathogens the clinical features of BVD can vary substantially (Ridpath, 2010). The 
findings of Chapter 3.2 confirm this statement: a 2-days-old calf was suffering from skin 
bleeding and the clinical presentation was indistinguishable from clinical manifestations 
observed in Bovine Neonatal Pancytopenia (BNP) affected calves. 
The bleeding syndrome in young calves became more relevant since BNP emerged in 
Europe in 2008 (Pardon et al., 2010). In this immunomediated disease allo-antibodies 
directed to calf leucocytes and bone marrow precursor cells are transferred to the calf through 
colostrum (Bastian et al., 2011; Bridger et al. 2011; Pardon et al. 2011). Although it was 
demonstrated that the presence of the allo-antibodies in colostrum was associated with 
vaccination with a particular BVDV vaccine (Sauter-Louis et al., 2012), only a small number 
of all calves that had received colostrum from vaccinated mothers developed BNP. It is 
assumed that the latter could be contributed to genetic predisposition of the calf (Deutskens et 
al., 2011). BNP presents itself by bleeding disorders all over the body in calves under 28 days 
of age. Haemorrhages are observed in the skin (spontaneous bleeding without primary 
trauma), eyes, external and internal mucosae and internal organs. Suspending sales of the 
vaccine associated with BNP in June 2010 was followed by a decreasing incidence of BNP. 
Nevertheless, sporadic cases are still reported in Belgium, since dams vaccinated before June 
2010 still can give birth to BNP calves today.  
The finding of a calf with similar clinical presentations as observed in BNP-calves is 
important for the differential diagnosis of BNP, but the case was exceptional for a number of 
reasons. First of all, the bleeding disorder was associated with persistent infection with a 
BVDV1 strain. Until recently, it was commonly accepted that HD was associated with 
BVDV2 (Blanchard et al., 2010), and several cases of BVDV2 related HD have been 
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reported (David et al., 1994; Carman et al., 1998; Ridpath et al., 2006). HD associated with 
BVDV1 has been described in older PI calves suffering from MD (Dabak et al., 2007). 
Thrombocytopenia has been mentioned in a report of an outbreak of severe disease associated 
with BVDV1 infection in the USA. The clinical presentations were abortion, premature birth, 
and congenital malformation. BVDV1b isolated from the affected animals was inoculated in 
calves and caused thrombocytopenia, but that change was not noticed in the field outbreak 
(Blanchard et al., 2010). Equally interesting was the observation that the calf of chapter 3.2 
was much younger than previously reported for HD. In a Belgian study on BNP the age of the 
affected calves ranged between 7 and 27 days (Pardon et al., 2010). A third remarkable fact 
was the thrombocyte count returning to normal in spite of persistent viraemia and, as a result, 
the persistently BVDV infected animal recovering from HD, whereas most calves suffering 
from BNP do not survive (Pardon et al, 2010). 
Sarrazin et al. (2013b), infected calves with the BVDV strain isolated from the case calf 
described in chapter 3.2 through intranasal instillation of 5 x 106 TCID50. The fact that the 
strain produced only subtle clinical signs in the experiment may be additional proof of the 
unpredictable clinical outcome of BVDV infection.  
In conclusion, due to the absence of any other clinical sign, the calf suffering from skin 
bleeding could have been mistaken for a BNP calf. Therefore, BVDV tests are necessary to 
complete the diagnosis of HD. 
In Chapter 3.3 it has been shown that infection with BVDV1b can cause life threatening 
disease in adult cows. Although leucopenia is a constant symptom of transient BVDV 
infection (Kapil et al., 2005), the complete absence of leukocytes at blood analysis was 
striking in this case. Herd mates of the affected cow suffered from haemorrhagic diarrhoea 
and pneumonia, a combination also mentioned in other cases of transient BVDV infection 
with severe clinical presentations (Carman et al., 1998; Amiridis et al., 2004). Not 
unexpectedly, management factors were likely to have been responsible for bringing BVDV 
into the herd. The most likely source of infection was a forklift truck used ten months before 
the BVDV outbreak to muck out sheds immediately after it had been used on another farm 
where cattle were afflicted by severe clinical disease associated with BVDV infection at that 
time. During the periparturient period the cow diagnosed with BVDV infection and severe 
proctocolitis had been housed in close contact with a 3-months-old PI calf and its peers. Even 
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after severe disease had damaged the herd, and BVDV had been diagnosed as the causative 
agent, the farmer was still reluctant to check the herd for presence of PI animals.  
Chapter 3.3 shows that even when infected with BVDV1, considered less virulent than 
BVDV2, adult cows can suffer from life threatening disease. As shown in this case, cows are 
particularly vulnerable in the postparturient period. Without laboratory testing for BVDV, the 
clinical presentations may be confused with other diseases causing haemorrhages, such as 
salmonellosis, coronavirus infection, coccidiosis, and haemorrhagic bowel syndrome. 
Moreover, by its immunosuppressive character, BVDV infection might also provoke those 
infections. 
Importantly, both cases of thrombocytopenia and HD described in chapters 3.2 and 3.3 
were associated with BVDV1b, a commonly diagnosed genotype in our area (Caij, B., 2013, 
personal communication), whereas Ridpath et al. stated in 2000 that all haemorrhagic 
syndrome outbreaks until that date had been associated with BVDV2 isolates. In 2010, 
Blanchard et al. confirmed that statement by concluding that thrombocytopenia is rarely 
associated with BVDV1 strains. The cases described in this thesis cannot be considered as 
“outbreaks” of severe disease, because the low number of affected animals involved. Still, 
also individual cases of severe HD associated with BVDV1 have rarely been reported.   
The results of Chapter 4 suggest that herds considered free of BVDV had lower BMSCC 
than infected herds. Although seroprevalence classes, as used in Chapter 4 are only estimates 
when measured as OD ratios, they give a reasonable indication of the antibody status of herds 
(Booth et al., 2013a). 
Strikingly, only 11.3% of the 243 randomly selected dairy herds could be classified as 
BVDV-free. Scottish research showed comparable figures: 12.7% of 220 dairy herds had a 
very low prevalence of seropositive cows (Humphry et al., 2012). Although a small fraction 
of the herds with low prevalence might have been recently infected, in general, the low 
antibody titre corresponds with absence of PI cattle (Houe et al., 2006). As bulk milk remains 
on average BVDV-antibody positive during 3.5 years after eradication of BVDV from a herd 
(Booth et al., 2013a), these very low prevalence herds are to be considered as BVDV-free for 
at least 3.5 years. Therefore, the conclusion has to be formulated as follows: herds that were 
BVDV-free for a number of years, had a lower subclinical mastitis prevalence as showed by 
the lower BMSCC. To assess the influence of management and to better understand the 
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association between BVDV status and BMSCC, a follow-up study to chapter 4 has been 
designed. The objective was to follow the evolution of the herd BMSCC from two years 
before eradication of BVDV until two years after eradication on 30 dairy farms that remained 
BVDV free after eradication. Unfortunately, the study had to be cancelled due to lack of 
suitable participants: not only did most farms with known BVD-free status lack a history of 
BVDV eradication, also was the actual BVDV status unknown on most farms where BVDV 
had been eradicated before.  
BVDV management in Belgium 
In Belgium continuing efforts have been made to familiarize farmers and veterinary 
practitioners with efficient BVDV control. Despite many scientific articles on BVD and 
continuous efforts of the Animal Health Services to provide information on the disease on 
their websites and in veterinary and agricultural press, farmers and veterinary practitioners 
seem to lack a basic understanding of the principles of BVDV control.  
In 2009 a student thesis revealed a lack of interest and participation of farmers in BVDV-
testing. When free BVDV spot tests were offered by a pharmaceutical company, 17 out of 50 
herds that received the results indicating that 60% or more young cattle were seropositive, 
which suggests presence of a PI animal, did not start tracking PI animals in the year after the 
positive test (Van De Steene, 2009). Similarly, in Chapter 5 of this doctoral thesis it was 
demonstrated that only 23% of 241 included farms monitored for BVDV and that 71% of 
BVDV vaccinating herds used vaccination as a strategy without knowing the BVDV status of 
the herd. Records on bio-security were not obtained, but according to other publications 
studying the Belgian situation, bio-security measures were also insufficiently implemented on 
Belgian cattle farms (Sarrazin et al., 2013b; Tay H., 2013). BVDV can stay in a herd for 
about three years, before causing a severe outbreak (Lindberg and Alenius, 1999). Without 
continuous monitoring, the virus can stay on the farm undetected, or re-enter the premises 
secretly after eradication. In contrast, when alarmed in a timely manner by a permanent 
monitoring programme, the farmer can put a stop to hidden damage to the herd, or prevent a 
severe outbreak by eliminating PI cattle in time. The results of insufficient monitoring 
correspond with a report from the United Kingdom. Monitoring was neglected there as well, 
even on farms participating in a voluntary BVDV control programme, where veterinary time 
and diagnostic testing were free of charge (Booth and Brownlie, 2012).  
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It has been estimated that BVDV vaccines are used in about 20% of livestock units in 
Europe (Moennig and Brownlie, 2006). Although there may be a difference between dairy 
and beef herds, this percentage corresponds well with the results of Chapter 4 of this thesis: 
in 2009, when the research studying the potential association between BVDV and udder 
health was conducted, 22% of the participating dairy herds were vaccinating against BVDV. 
A vaccination programme can reduce the incidence of acute and persistent infections in a 
herd or population, but will not prevent all new infections in individual cattle, and 
consequently, it will also not halt the development of PI animals (O’ Rourke, 2002; Lindberg 
and Houe, 2005; Ridpath, 2010; Ridpath, 2013). In the case of other infectious diseases, such 
as Infectious Bovine Rhinotracheitis, spreading of the infectious agent is substantially 
suppressed when almost all animals are protected by vaccine antibodies, because in that case, 
the infection load of the environment decreases substantially and the animal’s immunity can 
overcome the low infection pressure. For BVD the situation is different because of the 
exceptional role of the PI animal: if a single pregnant susceptible heifer or cow is not 
protected against intra-uterine infection, it can give birth to a PI calf, when infected in the 
first months of pregnancy. Moreover, protection by vaccination, efficient in a herd with low 
BVDV infection pressure through external contacts, may be insufficient to resist the immense 
virus shedding continuously caused by a PI animal living in the herd. Therefore, for proving 
the ability of a vaccine to protect against intra-uterine infection, the challenges should be 
conducted by exposing the test animals to long lasting contact with a PI animal (Ridpath and 
Fulton, 2009). Unfortunately, licensing requirements for validation of BVDV vaccine 
efficiency are currently based on challenge by a single intranasal inoculation of a field BVDV 
strain dose (Ridpath and Fulton, 2009). Another risk of disappointing vaccination results 
might be the ability of BVDV to rapid genetic and antigenic alterations. It remains to be 
studied if these changes could lead to vaccine failures due to differences between vaccine and 
field virus (Brock, 2003; Ridpath, 2013).  
The vaccine is often used incorrectly (Rauff et al., 1996; Moennig and others, 2005; 
Meadows, 2010); the prescribed timing of booster vaccinations may not be respected, or 
vaccine storage may be inaccurate, and most of all, herds often are only partially vaccinated. 
For BVDV vaccination strict administration is necessary, in particular when the farmer has 
chosen to vaccinate cattle individually before insemination, rather than vaccinating the entire 
herd twice a year. Finally, vaccination can convey the farmer a false sense of security and 
thereby lead to more risky behaviour, such as neglecting essential biosecurity measures 
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(Vannier et al., 1997; Lindberg, 2003; Moennig and others, 2005). At problem herd visits 
veterinarians of our department are frequently confronted with farmers thinking they cannot 
have BVDV problems, because the herd has been vaccinated. Through subsequent 
investigation, PI animals have often been detected. 
Despite the drawbacks mentioned above, vaccination can certainly play a role in 
controlling BVDV at the herd level. When starting the efforts to eradicate BVDV from a 
herd, it is advisable to start vaccinating at the same moment. Occasionally virus clearance is 
initiated shortly after birth of the first PI animals. In such a situation, the majority of the 
animals is still susceptible and vaccination will limit the number of animals becoming 
infected in early pregnancy (Lindberg and Alenius, 1999). Furthermore, a vaccinated herd is 
less susceptible to (re)infection from outside. Vaccination was effective in reducing the 
probability of positive BVDV test results in Irish herds (Graham et al., 2013). Finally, when 
BVDV infection occurs, less severe disease will occur in a vaccinated herd as compared with 
a susceptible, non-vaccinated herd (Ridpath, 2013). The latter is an economic advantage at 
first sight, but a disadvantage as well. As detecting BVDV infection through its clinical 
presentations is already difficult, the presence of BVDV will be even more masked by 
vaccination. As a result, birth of PI calves may continue, and as vaccination does not provide 
full individual protection, and often only a fraction of the herd is vaccinated (Borsberry, 
2012), some animals become at risk of infection again. The herd can suffer from hidden 
damage, and a more severe outbreak can occur. The more so, because many farmers stop 
vaccinating, or start vaccinating a smaller fraction of the herd when they suppose the herd to 
be free of BVDV for one or two years. In conclusion, vaccination can be a valuable element 
of BVDV control, but only as a part of the control scheme proposed by Lindberg and Houe 
(2005) (Barrett, 2012). Strict bio-security measures, removal of PI animals, and continuous 
monitoring are essential and vaccination can play a useful role as a complementary measure 
of bio-security (Lindberg et al., 2006), particularly in areas such as Belgium, with a high 
BVDV prevalence, a high cattle density and frequent cattle movements.  
After having summarized the shortcomings of BVDV control in Belgium, the question 
arises what could be the reason for this failing BVDV management. Although there is more 
and more information available on BVD, the message may be not sufficiently consistent. 
Maybe staff of the different organizations providing information on how to combat BVDV 
should confer more frequently and agree on a common and clear message. The issue is 
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complicated and therefore, offering a concise and uniform strategy message to veterinarians 
and farmers is essential. It has been emphasized before that, in all circumstances, 
communication is a key part of BVDV control (Lindberg and Alenius, 1999; Katholm, 2004; 
Barrett, 2012), as it is at any attempt to control a disease.  
Recommended BVDV eradication strategy at the herd level  
The 3 case reports and the observational study included in Chapter 3 emphasize that 
recognizing the presence of BVDV infection in a herd through its clinical presentations is 
often impossible, and seldom reliable, both at the animal and the herd level (Lindberg and 
Alenius, 1999; Ridpath, 2003; Evermann and Barrington, 2005). As a result, the only 
appropriate way to diagnose circulation of BVDV in a herd is through repetitive sampling 
and testing. Moreover, a disease that is not easily recognizable by its clinical features has to 
be monitored on a regular basis, both in herds supposed to be free of BVDV and herds where 
BVDV has been eradicated. 
The recommended method for approaching BVDV eradication as formulated by the 
Belgian Animal Health Services and Veterinary Faculties has been presented in the general 
introduction, more specifically in Figure 4. This method has proven to be efficient in practice. 
Nevertheless, strict discipline and special attention to potential pitfalls are necessary for 
success. Hereafter, points of attention for BVDV eradication at the herd level will be 
discussed. It is the veterinary practitioner in particular who has the important task of 
designing a herd specific control programme as efficient as possible, by bearing in mind these 
potential pitfalls. Next to keeping the administration up to date, she/he can motivate the 
farmer and has to remain the main source of information on BVD. 
Points of attention for BVDV eradication at the herd level  
Administration 
In Belgium both BVDV prevalence and cattle density are high (Sarrazin et al., 2013a). 
Therefore, re-infection of a herd with BVDV after eradication is likely and direct or indirect 
contacts with cattle of neighbouring farms are among the potential sources for between-herd 
BVDV infection (Presi et al., 2011; Ersbøll et al., 2010). Nevertheless, when visiting herds 
with a BVDV problem, it often has been experienced that the origin of a recently detected 
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BVDV infection is not re-infection, but a PI animal overlooked during the previous 
eradication attempt. When interviewed on BVDV, the farmer regularly states that all cattle 
have been tested, but when checking the records, it becomes obvious that a few or more cattle 
have never been sampled and tested. In many cases a PI animal is still present in this group. 
Hence, when eradicating BVDV from a herd, it is of utmost importance that every single 
bovine present on the farm has been virologically tested as well as every calf born within the 
year after removal of the last PI animal from the farm (Houe et al., 2006). All these actions 
cannot be completed correctly without meticulous administration. Through experiences in the 
field, it seems as if failing administration is the most important reason for overlooking PI 
cattle. It also has been shown in literature that incorrect administration can be an issue in 
other fields of livestock management, such as genetic evaluation (Ron et al., 1996; Bertrand 
and Wiggans, 1998).  
Male calves 
Calves destined for fattening may only stay on the farm for a very short period of time 
and to reduce costs these animals are often not included in a BVDV screen. In addition, virus 
excretion by PI calves is partially suppressed by colostral antibodies (Baker, 1987). Some of 
the PI calves however, are able to infect a pregnant cow and her foetus with BVDV in spite 
of the short time they are on the farm so leading to the birth of another PI calf. Occasionally 
one of these bull calves may stay on the farm and maintain BVDV infection in the herd. 
Although it may be of relatively minor importance, the risk of not testing male calves exists 
(Lindberg and Houe, 2005). All bovines present on the farm have to be tested, even when 
they leave soon after birth. The problem of the male calves might be solved if the calf 
fattening sector would make a demand to BVDV certification for all calves admitted to 
fattening units. 
Geographically segmented farms 
Some farms are divided into two or more geographical units. On mixed farms, for 
example, beef cattle can be housed apart from the dairy cows and their offspring. Sometimes 
young stock are reared on another farm, or common pastures may be used. In these cases and 
every time frequent contact between cohorts occurs, all parts must be considered as one entity 
for testing. If not, a unit where the BVDV has been eliminated can become infected again via 
another, un-checked unit (Rosmanith et al., 2005). Moving animals between units is not the 
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only way BVDV can spread. Albeit rarely, people and contaminated medicines are also 
potential viral vectors (Niskanen and Lindberg, 2003; Ståhl et al., 2005). On some farms 
groups of young stock may be housed apart, for example beef and dairy young stock. 
Following the eradication of BVDV from such a herd, every sub-section of that herd must be 
sampled by serological testing of young stock every 6 months to ensure comprehensive 
monitoring.  
Colostral antibodies 
In young calves the presence of colostral antibodies against BVDV can cause false 
negative results in the detection of PI calves (Fux and Wolf, 2012). This “diagnostic gap” is 
another important point of attention for PI detection. This issue has been the subject of ever 
changing opinions on which test is reliable until what age of the calf. Previously, it was 
generally accepted that colostral antibodies influenced the result of an ELISA (Lindberg and 
Alenius, 1999; Zimmer et al, 2004), but never the result of a PCR test, even if used for pooled 
blood samples. Although the number of contributors to the pool might play a role (Booth and 
Brownlie, 2012), nowadays it is understood that PI calves can be missed likewise when pools 
are tested by PCR. The presence of blood from calves under two months, still containing high 
levels of maternal antibodies, can be the cause of potential failure (Martin Beer, personal 
communication). When using RT-PCR on individual blood samples, there is no “diagnostic 
gap” (Martin Beer, personal communication). The same holds for RT-PCR on ear notch 
samples (Fux and Wolf, 2012). For Erns ELISA used on individual blood there is a gap for 
calves under 60 days-of-age and for RT-PCR on pooled blood samples until 40 days of age. 
When using Erns ELISA on ear notch tissue, the effect of colostral antibodies is very limited. 
Because of the minimal risk of false negatives, the test is used in practice anyway, but one 
has to bear in mind that exceptional false negative results are possible (Presi et al., 2011; Fux 
and Wolf, 2012). Briefly, it is recommended to test calves under two months of age only by 
ear notch samples, as the only alternative, the individual PCR test for blood is rather 
expensive. Sometimes precolostral testing is employed to avoid influence of colostral 
antibodies, specifically on Belgian Blue farms were almost all calves are delivered by 
caesarean section. As experienced in our ambulatory clinic, this method is extremely 
susceptible to mistakes, because the farmer usually places the official ear tag after sampling 
by the veterinarian and, as a result, incorrect identification is likely, messing up the 
administration.  
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Purchasing policy. 
BVDV is frequently introduced into a herd by newly acquired cattle (Mainar-Jaime et al., 
2001; Doll and Holsteg, 2013). In their study on risk factors associated with BVDV infection 
in Irish beef and dairy herds, Graham et al. (2013) emphasize the importance of adequately 
addressing the risk presented by purchased cattle through testing these animals before or after 
the movement. Testing these cattle for BVDV viraemia is essential but does not exclude virus 
introduction: as long as the outcome of the blood test is not known, the purchased animal 
must stay in strict quarantine, with no direct animal contact and with the implementation of 
other hygiene measures such as changing footwear and work clothes by attendants before 
entering and leaving the quarantine area. Attention must also be paid to the risk of the 
“Trojan” cow or heifer. If a susceptible pregnant animal is infected during the first 125 days 
of gestation, it will have eliminated the virus after about ten days. The dam will then become 
seropositive, but its calf will be PI. When purchased towards the end of gestation, such a cow 
can carry BVDV onto the premises in its PI calf. Consequently, not only the purchased 
mother (Trojan cow) has to be virologically tested, but also her calf. One must also realize 
that the dam, BVDV-free herself, can shed substantial amounts of BVDV through the foetal 
fluids at giving birth to a PI calf (Lindberg et al., 2004). 
Spot tests 
Serological testing of a restricted number of young stock (spot test) is still a tool of choice 
for detecting PI cattle, particularly in areas of high BVDV prevalence (Booth and Brownlie, 
2012). Both sensitivity and specificity of the spot test are high for detecting PI cattle within 
young stock (Valle et al., 2005), on condition that the selected animals are representative for 
the group (Houe et al., 2006; Booth et al., 2013b). For example, it is necessary to exclude 
recently purchased cattle or animals that were not part of the herd when they were young. If 
young stock has been separated in groups for management reasons, the herd has to be tested 
by a spot test for each group (Houe et al., 2006). Repeating the spot test regularly is very 
important to improve its sensitivity (Lindberg et al., 2006; Booth and Brownlie, 2012). 
Combining it with other tests such as bulk milk PCR testing or serology also enhances the 
chance to detect PI animals in the entire herd.   
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Virological testing of bulk milk samples 
Testing for BVDV on bulk milk samples is popular, because a lot of cattle can be tested 
with little effort. The prevalence of BVDV in Belgium is still high (Sarrazin et al., 2013a) 
and cows remain lifelong seropositive after a transient BVDV infection. As a result, bulk 
milk of farms where BVDV has been eradicated efficiently can remain seropositive during up 
to 3.5 years (Booth et al, 2013a). Evidently, if the farmer continues to buy antibody positive 
animals, this period can be prolonged. Therefore, testing bulk milk for BVDV-antibodies to 
confirm freedom of BVDV is not the method of choice in an area with high BVDV 
prevalence, except when a herd is supposed to be free of BVDV since at least 3.5 years 
(Lindberg and Alenius, 1999). Moreover, as also confirmed in Chapter 4 of this thesis, 
vaccination antibodies can contribute to an increase of the BVDV-antibody titre of bulk milk 
(Booth et al., 2013a). Actually, in Belgium, bulk milk samples are collected mostly at the 
occasion of herd level eradication attempts to be examined through RT-PCR for detection of 
PI animals among the lactating cattle. It is obvious that this PCR milk test alone is not an 
efficient tool for testing the entire herd, because about 90% of all PI cattle are younger than 
two years (Presi et al., 2011). On the other hand, combining a bulk milk PCR test with a 
young stock spot test, both conducted at regular intervals (e.g. every six months), increases 
the value of the spot test, as via the bulk milk PCR test presence of an adult PI animal can be 
detected, while the spot test might be negative in the case of very strict separation of cows 
and young stock. As always, correct administration also is important for detecting PI cattle 
via bulk milk. If, on future occasions, such as an investigation in case of re-infection of the 
herd, the farmer knows which cows and heifers have been tested via a bulk milk sample, time 
and costs can be saved. In practice farmers often know which cattle have been tested by 
blood tests in the past, but that is rarely so for bulk milk test results. Obviously, a bulk tank 
milk sample is only representative of the animals that have contributed milk to the tank at the 
time of sampling. All other cattle have to be blood sampled. This may seem obvious but any 
cow(s) whose milk was excluded on that day (for example because of antibiotic treatment) 
may well be overlooked. Blood samples are needed from these cows and also from any cows 
in the dry period. As PI animals can live beyond two years (Presi et al., 2011), not a single 
adult bovine may be overlooked for testing, including any stud bulls (which can easily be 
forgotten as they may be housed in isolation).  
  
Chapter 6      General discussion 
137 
 
Intermittent viraemia in persistently infected cattle 
PI cattle are a major factor in spreading BVDV, because they are persistently viraemic 
and shed large amounts of virus continuously throughout their lifetime. However, there are 
indications that the viraemia can transiently diminish, specifically when a PI animal is 
infected by a heterologous BVDV strain, which results in the production of antibodies that 
cross-react with the strain of the PI animal. In this case, the viraemia is diminished as long as 
the antibody titre remains increased (Brock et al., 1998). No data is available on viral 
excretion during such a period, but this temporary interruption of viraemia might result in 
reduced virus shedding and lead to PI animals escaping detection if the amount of virus in the 
blood is lower than the detection level at the moment of sampling. As the likelihood of two 
different BVDV strains circulating on one farm at the same moment is exceptional, the 
phenomenon of intermittent viraemia is rather theoretical and of minor practical importance 
to BVDV eradication.  
Disposal of PI animals 
The high value of the Belgian Blue cattle makes the decision to euthanize a PI animal 
even more difficult. Houtain (2012) has showed that, although participating in a voluntary 
BVDV control project, some farmers kept PI animals on the farm for longer than one year 
after they had been diagnosed PI. Minimizing the time it takes for PI animals to be 
slaughtered also appeared to be important for the success of the eradication campaign in 
Switzerland (Presi et al., 2011). It is the delicate task of the veterinarian to ensure timely 
disposal by persuading the client of the necessity for action. Importantly, the one year period 
of testing all newborn calves only commences when the last PI animal leaves the farm, not 
when it has been detected. 
Accuracy of laboratory tests and procedures 
The tests commonly used for detecting BVDV in blood, milk, and ear notches are among 
the most reliable. The antigen ELISA currently in use have been shown to be almost equally 
as sensitive as RT-PCR. Mars and Van Maanen (2005) showed that the Erns antigen ELISA 
has 99% sensitivity and 99.5% specificity as compared to RT-PCR. In RT-PCR assessments 
the detection limit for PI animals in white blood cell fractions was 1:2048. Hilbe et al. (2007) 
demonstrated that three antigen detection methods and real time RT-PCR used in parallel had 
a high correlation rate of 96.5% in recognizing persistently BVDV infected animals. As a 
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result, BVDV tests are not commonly considered as a major source of error in identifying PI 
animals (Lindberg and Alenius, 1999) and failures in animal identification must be excluded 
before accusing the laboratory or the test. Nevertheless, research (Fux and Wolf, 2012) and 
records obtained in the field show that false negative results, albeit rarely, can be an issue. In 
the third phase of the Swiss control programme false negative results of ear notch tests 
accounted for 57% of the 168 identified sources of infection (Presi et al., 2011). In a control 
programme applying ear notching of newborns as the only strategy, it takes a minimum of 
two years until those previously undetected PI animals are identified via their offspring. 
Repeated serological young stock tests every six months alert earlier, since they are evidence 
of BVDV circulation among young stock (Houe et al., 2006). Furthermore, correct 
interpretation of the test results is necessary for drawing correct conclusions. As the 
knowledge of BVDV evolves constantly, the interpretation of a test result can change over 
time. Therefore, continuous education and training for veterinarians is highly important to 
BVDV control (Lindberg and Alenius, 1999).  
BVDV control at the national level 
Lindberg et al. (2006) stated that the main difference between BVDV control strategies is 
not implementation at the herd level or national level, but whether a strategy is systematic or 
not. The authors define a systematic approach as a goal-oriented reduction in the incidence 
and prevalence of infections. In systematic control, biosecurity measures are implemented, PI 
animals always removed, and BVDV-free status and progress are monitored and evaluated 
(Lindberg et al., 2006). Combination of these three measures is possible in voluntary BVDV 
control attempts at the herd level. When attention is paid to the pitfalls listed above, 
successful BVDV eradication at the herd level is achievable. Nevertheless, voluntary BVDV 
control strategies seem to fail (Letellier et al., 2005; Booth and Brownlie, 2012; Houtain, 
2012). Moreover, the results of Chapter 5 of this thesis show that BVDV control in Belgium 
is not systematic at all, hence inefficient (Lindberg et al., 2006). It can be concluded that 
systematic control at the national level, mandatory and with a legal basis, is the only efficient 
way to deal with the BVDV problem (Moennig et al., 2005; Barrett et al., 2011).  
In Belgium, persistent BVDV viraemia is a defect that gives ground for annulment of sale 
of individual cattle. To date, this measure is the only legislative rule concerning BVD in 
Belgium (Belgisch Staatsblad, 2009). Recently, the decision has been taken to start a 
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national, mandatory BVDV eradication programme. A study group has been composed with 
representatives of the Belgian authorities, farmers’ and veterinarians’ unions, the veterinary 
statutory bodies, the animal health services, the national reference laboratory and both 
faculties of veterinary medicine. The exact guidelines are still under discussion, but the 
intention is to implement a national control resembling the German and Irish BVDV-
programmes, including obligatory testing of all newborn calves using ear notching during 
several years. In the following section of the general discussion the Belgian BVDV control 
plan as it is under design will be explained. Subsequently, an ideal BVDV eradication 
strategy will be described, based on literature and the aforementioned points of attention for 
BVDV control at the herd level. Finally, through omitting unrealistic or expensive parts of 
the ideal plan, a proposal will be made for a realistic, achievable BVDV control plan, able to 
result in eradication within an acceptable period of time.  
The Belgian BVDV eradication plan as it is actually designed 
The future Belgian BVDV eradication programme as it is under design today will be 
executed in a number of steps, as explained in Figure 1. It is the intention to change the rules 
gradually with the lapse of time from rather simple and tolerant during the first stages to more 
and more stringent in later phases. 
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Figure 1. The different steps of the future Belgian BVDV eradication programme as 
designed in November 2013.  
In step 1 preparatory activities will be started. A year later, in step 2, mandatory ear 
notching will be implemented. The basis of the programme will consist of obligatory testing 
of all newborn calves by ear notch samples within 7 days after birth. The official individual 
identification document will not be delivered, unless the calf has been tested for BVDV. PI 
animals will be stigmatized as PI on their identification document. Hence, a BVDV positive 
calf will have to stay on the farm of origin, since in Belgium cattle movements are not 
allowed without identification document. A BVDV positive animal will be considered PI 
until proof to the contrary has been provided. Dams of PI calves will have to be tested for 
BVDV viraemia. In the first year there will neither be an obligation to immediate slaughter or 
to euthanasia of PI animals, nor to obligatory testing at purchase. Still, measures for 
immediate removal of PI cattle will be imposed from January 2016. Compulsory screening to 
detect other PI animals present in herds where a PI has been detected will not be implemented 
from the start. Moreover, serological surveillance will not be part of the initial programme, 
but will be initiated later. From January 2017 on (step 4), herds where all cattle have been 
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tested individually will have the possibility to voluntarily stop ear notch testing, receive the 
BVDV-free herd status and change to surveillance by serological testing. In step 4 testing at 
purchase will become mandatory for cattle without an individual BVDV status. A BVDV-
free certificate will be attributed to all calves that have tested BVDV negative within the first 
7 days of life and to the dams of all calves that have tested negative for BVDV since the start 
of the programme. Animals tested BVDV-free with other tests than the obligatory ear notch 
test for neonatal calves will also receive such a certificate, in addition to cattle that were 
individually tested non-PI before the start of the programme. A distinction will be made 
between certificates: animals tested for BVDV will receive the “BVDV PI free” certification, 
whilst dams of non PI calves will receive the “BVDV PI unsuspected by progeny” certificate. 
At purchase the BVDV certificate will lift the obligation of BVDV testing.  
The ideal BVDV control strategy for Belgium 
Although it took ten years of continuing efforts, the Scandinavian countries have been 
successful in eradicating BVDV and maintaining the free, or almost free status at the national 
level (Lindberg et al., 2006). In contrast to Switzerland, Scandinavia could not dispose of the 
ear notch test, a recently available method for PI detection. In view of the rapid success and 
cost-efficiency of the Swiss eradication programme (Presi and others, 2011), it is evident to 
take this strategy as an example for Belgium. The Swiss programme took advantage of both 
the recent ear notch test for detecting PI cattle and serology for monitoring, as the latter 
method had already proven its efficiency in Scandinavia. Hereafter elements for an ideal 
BVDV eradication strategy in Belgium are listed. 
On the one hand, using simple and clear rules is important for compliance of the 
stakeholders, but on the other hand, the missing of PI cattle must be avoided at all times. 
False negative test results with samples from a PI animal is perhaps the greatest threat to the 
success of BVD control programmes (Sandvik et al., 2005). It can be argued that the number of 
missed PI cattle is small and, as a result, negligible in a national programme. Nevertheless, 
the role of PI animals is extremely important and the effect one PI animal has on a herd is not 
negligible at all. In the first two years of the Swiss eradication programme false negative 
results of ear notch tests accounted for 57% of 168 identified sources of infection (Presi et al., 
2011) and a single PI calf missed by a false negative test was found responsible for the birth 
of 20 new PI calves after it entered different herds (Di Labio, 2012). The risk is that, once 
(falsely) certified as BVDV-free, the PI animal can be moved from one herd to another. 
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Moreover, when a misclassified PI animal stays in the herd or enters another herd with a 
BVDV-free certificate, it is very likely that the farmer and his veterinarian will exclude BVD 
from the list of differential diagnoses, when clinical signs related to BVDV appear. 
Preceding determination of BVDV prevalence 
Because prevalence records allow making decisions on test strategies, it is preferable to 
conduct a BVDV prevalence study before launching the BVDV eradication programme. In 
Belgium the BVDV prevalence has been investigated by Sarrazin et al. (2013a), using 
samples collected for a national survey on Blue Tongue virus infection. The results have been 
mentioned in the general introduction. 
Systematic strategy is essential 
Undoubtedly, to be efficient, a BVDV control strategy has to be systematic. When 
attempts to eradicate BVDV have failed in the past, a common finding is that they lacked one 
or more of the three essential elements of BVDV control: biosecurity aimed at preventing 
(re)introduction of the infection in free herds, elimination of PI animals from infected herds, 
and surveillance to monitor the progress of interventions and to rapidly detect new infections 
(Lindberg et al., 2006). If one or more of these elements are not part of a control programme, 
it is by definition non-systematic, hence inefficient.  
Necessity of an information campaign  
Interest of farmers and veterinary practitioners is a key factor for making a BVDV control 
programme successful (Hult and Lindberg, 2005; Moennig et al., 2005; Lindberg et al., 2006; 
Barrett et al., 2011; Barrett, 2012; Graham et al., 2013). Therefore, an intensive information 
campaign, designed and conducted in the approved manner, is needed at least one year before 
the start of the programme itself. The Swiss compulsory BVDV programme serves a good 
example, where an intensive communication campaign was run before launching the 
programme, thus raising awareness of BVD and, as a result, the motivation of farmers and 
veterinarians (Presi et al., 2011). First and foremost, farmers must be persuaded of the long 
term profits of the programme for their business. An example of an important issue for the 
information campaign is making clear that leaving a PI animal in the herd causes financial 
losses that are much higher than the value of the PI animal, even though it might be very 
valuable. Nevertheless, messages must not only be directed to farmers; veterinary 
Chapter 6      General discussion 
143 
 
practitioners are similarly important stakeholders. The practitioner is aware of the herd 
situation, is the most approachable and competent person for herd health matters and knows 
the clients’ character and personal behaviour. As a result, she/he is the right person to involve 
farmers in a BVDV control programme. On the other hand, if the veterinarian is not 
persuaded, or insufficiently involved in the programme and therefore not enthusiastic, she/he 
can have a very negative effect on farmer’s compliance. Therefore, veterinarians must be 
well informed long before the start of the campaign, should be involved in designing the 
programme. A clear role in the execution of sampling procedures and implementation of herd 
measures must be allocated to the veterinary profession.  
Short term eradication 
Both terms “control” and “eradication” are used in literature to refer to different degrees 
of BVD reduction. Control is “the purposeful reduction of specific disease prevalence to a 
relatively low level of occurrence, though transmission occurs frequently enough to prevent 
its permanent disappearance”. Eradication is “the purposeful reduction of specific disease 
prevalence to the point of continued absence of transmission within a specified area by means 
of a time limited campaign” (Houe et al., 2006). These definitions point to the continuous 
high costs of a control programme as compared to the time-limited investment of eradication 
(Houe et al., 2006). As protracted control programmes are more likely to allow the virus to 
re-emerge in herds where the BVDV has been previously cleared, an intensive, short-term 
campaign is preferable to a more protracted one. Finally, if the campaign takes too long, 
momentum is likely to be lost and enthusiasm and cooperation likely to wane (Barrett et al., 
2011). To maintain good support from the stakeholders and confidence in the measures 
imposed, promising progress within the first few years is very important (Lindberg et al., 
2006).  
Testing all animals of all ages 
Testing of all animals of the population is ideal. In the Swiss programme, not only calves 
have been tested, but from the start all other cattle were tested too, except animals on 
fattening farms (Presi and Heim, 2010). Testing only newborn calves inevitably slows down 
the progress of eradication and prolongs the duration of the campaign. As a result, associated 
program costs and disease related financial losses increase. The Swiss economic and 
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epidemiological circumstances differ from the Belgian situation. Still, the Swiss programme 
remains a good example. 
Ear notches tested by RT-PCR as the preferred test method for PI detection 
Ear notch testing is a reliable method for detecting PI animals (Cornish et al., 2005). The 
method has proven to be practical and efficient in Switzerland. Albeit exceptional, false 
negative results due to the presence of colostral antibodies are possible when using the 
antigen ELISA for testing ear tissue (Fux and Wolf, 2012). The problem does not occur when 
ear tissue is tested by RT-PCR (Fux and Wolf, 2012). Hence, allowing the PCR test as the 
only method for testing ear notches must be considered when drawing up the rules of the 
Belgian programme.  
Meticulous record keeping 
Similar as for the control at the farm level, correct identification of animals and samples 
is key to successful BVDV control. Ear notch testing allows correct identification of samples, 
as the container where the ear tissue falls in is identified by the animal’s official number. 
Correct record keeping will not be an issue for a future Belgian plan, because the well 
elaborated Belgian animal identification and registration database, Sanitel, is available for 
that purpose. Nevertheless, adjustments will be necessary to facilitate integration of BVDV 
records into the Sanitel database and make the system user friendly.  
Mandatory testing for BVDV viraemia at purchase 
Purchasing pregnant cattle in particular is a well known risk of infection to a herd and 
preventing introduction of PI animals or dams carrying PI foetuses is essential to biosecurity 
policy of a systemic BVDV control strategy (Lindberg et al., 2006; Dubovi, 2013). In an 
ideal BVDV control programme, every newly acquired bovine that enters a herd has to be 
tested for BVDV viraemia and put in strict quarantine until the test result is known. From an 
epidemiological point of view, BVDV testing at the farm of origin before cattle movements 
would even be better. To tackle the problem of the Trojan cow, the calf also has to be tested. 
The latter will be no issue in an eradication plan based on testing of all newborns. 
Nevertheless, during the first 48 hours after calving non-PI dams that gave birth to a PI calf 
spread BVDV through vaginal fluids (Lindberg et al., 2004). In this way a herd may become 
infected before the ear notch test result is known. This might cause acute disease in a 
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(partially) BVDV-free herd and birth of new PI calves afterward. This phenomenon makes 
quarantine even more important. Finally, it is evident that all cattle imported from other 
countries have to be BVDV tested. 
Accurate procedures and laboratory tests  
To avoid discussions afterward, clear standards for use and interpretation of the 
diagnostic tests must be set in time (Moennig et al., 2005; Valle et al., 2005; Lindberg et al., 
2006). Although substantial literature has been published on diagnostic methods, the 
prevalence of BVDV, cattle density, animal movement frequency, and cattle housing 
management can differ between countries. Therefore test methods must be adjusted to each 
national programme. For example, interference of vaccine antibodies with serological results 
must be determined and sample sizes requirements needed for accurate serological testing 
stipulated. 
False positive results are a negative economic side effect, as opposed to a real eradication 
programme problem. Nevertheless, a clear definition of a PI animal should be established in 
the Belgian programme, to avoid false positives. The fact that by PCR tests BVDV-RNA can 
be detected during a much longer period than viable BVDV (Givens et al., 2009; Sarrazin et 
al., 2013b) should be taken into account at formulating such a definition. Therefore, antigen 
ELISA may be more appropriate than RT-PCR to confirm the PI status at repeated sampling 
three weeks after the initial sampling. On the other hand, antigen-ELISA may produce false 
negative results when calves under two months of age are tested, because of the diagnostic 
gap. In the actual Belgian legislation on annulment of sale the RT-PCR test is not registered 
to confirm the PI status at second sampling. 
Mandatory immediate disposal of PI animals 
The early identification and prompt elimination of PI cattle from the population is the 
foundation of any successful BVDV eradication programme (Barrett, 2012). In an ideal 
programme, immediate culling (within one week) of PI animals is obligatory and verified via 
the national identification and registration system. 
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Early implementation of monitoring procedures 
Monitoring is important to evaluate the progress of the programme. Many of the pitfalls 
in the detection of PI cattle mentioned previously in this discussion can be countered by 
(early) implementation of obligatory herd serological monitoring. For example, half yearly 
serological tests highlight the missing of a PI calf at ear notch or other testing due to presence 
of colostral antibodies. The same holds for missing a PI heifer or cow by incorrectly 
registered dam-calf relation. A repeated serological test also indicates BVDV circulation 
when a “Trojan cow” has infected the herd at calving. Finally, positive serology caused by 
postponed disposal of a PI animal might make clear to the farmer that it is high time to cull 
the PI animal. The young stock serological test (spot test) has proven to be efficient in 
detecting herds housing PI animals (Valle et al., 2005; Houe et al., 2006; Booth and 
Brownlie, 2012; Booth et al., 2013), but the test has to be representative for the herd.  
In the initial stage of an eradication programme bulk milk serology is not useful for 
detecting BVDV circulation, except when titre increase would be measured, since most herds 
will still be seropositive at the start of the programme (Sarrazin et al., 2013a) and it takes up 
to 3.5 years for a herd to become seronegative after eradication (Booth et al., 2013a). In a 
later phase, when most herds are seronegative, serological bulk milk testing can be started. 
For beef herds, it could be investigated if pooled serum samples could be used at that later 
stage. 
Importantly, virological testing of all newborn calves is a valid method for decreasing the 
PI cattle prevalence, but not for monitoring the BVDV-free status of a herd (Houe et al., 
2006). Combining virological testing of all newborns with regular serological testing of 
young stock (spot tests) would be ideal.  
As long as a BVDV eradication programme does not implement surveillance, it remains 
to be considered as non-systematic, hence inefficient (Lindberg et al., 2006). Therefore, 
monitoring by regular serological young stock tests must be implemented not later than one 
year after the start of obligatory ear notch testing.  
In the final stage of the programme molecular surveillance of circulating strains can be 
added to the surveillance policy, to trace routes of infection between the few remaining 
infected herds (Ståhl et al., 2005). Continuous collection and evaluation of genome data of 
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circulating BVDV strains can also provide an early warning system in case of introduction of 
exotic strains (Lindberg et al., 2006).  
Representative sampling 
The pitfall of spot testing on farms composed of separate geographical units may be 
relevant at controlling BVDV at the herd level, but also for Belgian national programme. On 
farms where groups of cattle such as young stock of beef and dairy cattle are housed in the 
same geographical unit, but rather separately in different barns, serology (spot test) of each 
group is necessary to obtain a representative sample of the herd (Houe et al., 2006).  
Prevention of re-infection 
Farmers must be conscious of the risk of re-infection. The information campaign has to 
not exclusively deal with the economic consequences of BVDV infection, but also highlight 
the high risk of infection associated with certain management practices (Presi et al., 2011). 
Albeit high in the initial phase of the programme, the prevalence of PI cattle will decrease 
gradually (Presi et al., 2011). As a result, the risk of re-infection will be reduced, but more 
and more cattle will lose BVDV-antibody protection and become susceptible to BVDV 
infection. Monitoring by regular serologic tests is the tool of choice for detecting potential re-
infection of herds. Obviously, testing of the entire herd and movement restrictions must be 
imposed for herds suspected of housing PI animals. 
Record availability 
Stakeholders must have timely access to accurate and updated information on BVDV 
statuses of herds. In that way farmers who are aware of the risks of BVD can make better 
decisions. Moreover, this information motivates stakeholders. Therefore, diagnostic results 
have to be available at any moment for farmers, livestock traders, and veterinarians (Lindberg 
et al, 2006). When farmers are aware of the BVDV statuses of neighbouring herds, they will 
guard against breaking movement restriction rules when these would be imposed. 
Notes on vaccination and the national programme 
Vaccination can be very useful in the first phase of the systematic control programme as 
an additional measure of biosecurity (Lindberg et al., 2006). Because more and more cattle 
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will become at risk of infection, vaccination will be advantageous to provide additional 
protection against re-infection of herds until the national BVDV prevalence becomes 
negligible. On the other hand, since there is no marker vaccine on the market at the time of 
publication of this thesis, vaccine antibodies can disturb young stock serological monitoring. 
For that reason, it would be preferable to impose a ban on vaccination of cattle younger than 
14 months prior to implementation of monitoring by young stock serology. On the other 
hand, as long as vaccines for adult cattle are available, farmers who prefer to continue 
vaccinating young stock against BVDV, might use these vaccines in cattle under 14 months. 
Hence, imposing a vaccination ban for only one age group might be unrealistic. Furthermore, 
when regular serological bulk milk testing will be implemented in the end phase of the 
Belgian programme, a vaccination ban could be imposed, for vaccine antibodies cause false 
positive results (Booth et al., 2013a). If, through the information campaign, farmers are 
taught that in the phase of herd certification (from step 3 onwards) vaccination will only 
delay the attribution of the BVDV-unsuspected status to the herd, a ban on BVDV 
vaccination might even be obsolete. 
Proposal for a realistic Belgian BVDV eradication programme 
It will be up to the authorities to decide which parts of the ideal programme as proposed 
in this thesis will be implemented in the Belgian BVDV control programme. Obviously, the 
costs of potential measures are a limiting factor and controlling BVDV will need a 
continuous effort to balance the epidemiologically and economically optimal approach. 
Concise regulations, easy to explain and adaptable 
Even if the control strategy is not optimal from the start, the ultimate object can still be 
achieved, if the programme allows for flexibility of the regulations (Hult and Lindberg, 
2005). Especially at the start, the programme has to be concise and the rules simple to 
explain. The intention must be to immediately reduce prevalence of PI animals and as a 
result, the number of infected herds. In the later phases more stringent and detailed measures 
can gradually be added.  
A systematic programme with the objective of eradication 
As stated before, a national BVDV programme has to be systematic and it has to be an 
eradication programme to have a chance of success. 
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By definition, an eradication programme achieves permanent absence of transmission in a 
short term. For the Belgian programme, as currently proposed by the study group, this period 
will be long, because only newborn calves will be tested, immediate removal of PI animals 
will not be imposed, and there will be no obligation for farms housing a PI animal to be 
screened for other PI animals. Therefore, early transition to further steps with more strict 
regulations is necessary to obtain an acceptable eradication period. 
The “triangle of Lindberg and Houe”(Figure 2), represents the three essential elements of 
systematic BVDV control. Decision makers should always bear this image in mind when 
drawing up rules for the programme.  
 
Figure 2. The three essential principles of systematic BVDV control as stated by 
Lindberg and Houe (2005), with vaccination as a potential fourth measure.  
Biosecurity is the basis of systematic BVDV control. Efficient biosecurity, particularly at 
the onset of the programme, has to be focused on preventing direct contact with animals of 
unknown or infected BVDV status. In contrast to implementation of PI detection and 
monitoring, imposing and supervising biosecurity measures may be difficult to achieve in an 
official programme. The alternative for the Belgian programme is to improve biosecurity via 
an intense and continuous information campaign. Clear guidelines for efficient biosecurity 
policies have to be provided long before launching the test programme. Messages pointing to 
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the risks of certain management practices have to be repeatedly directed to the stakeholders. 
Correct information is necessary for other reasons too. For example, information on progress 
of the strategy is needed within the first few years of the programme to maintain a high level 
of interest among farmers and veterinarians. Furthermore, correct and up-to-date data on 
BVDV status of herds must be readily available to all stakeholders. 
For the second element of any systematic approach, detection and removal of PI animals, 
ear notch testing actually appears to be the right choice for a national eradication programme. 
Utilization of the ear notch technique substantially reduces the risk of identification failures 
and false negative results are exceptional. Nevertheless, because testing ear tissue by RT-
PCR is less susceptible to false negative results, this method should be preferred to antigen 
ELISA. Until the time of submission of this thesis, it has not been decided which virus test(s) 
will be used for the programme. 
Regulation and monitoring of immediate culling of PI animals is easily achievable, as PI 
animals will be known to the Sanitel system and through the same identification and 
registration system checks can be made to establish when the animal is euthanized or 
slaughtered. Nevertheless, the overall feeling is that in Belgium such a regulation would met 
with fierce resistance, if implemented from the start of the programme. This observation 
highlights the lack of knowledge on the potential costs associated with presence of a PI 
animal. Another potential cause of resistance could be insufficient solidarity between 
farmers. One opinion might be to provide (partial) refund of culled PI animals. The high 
economic value of Belgian Blue cattle makes refunding of the entire value of such a PI 
animal problematic for the programme budget. Paying a fixed amount for every animal, 
might satisfy most dairy farmers, but is markedly insufficient for calves with high genetic 
potential and Belgian Blue cattle. At this point the role of an information campaign started in 
time is crucial to convince farmers of the threat such a PI animal can be to health and 
productivity of a herd. Moreover, farmers could be forced to cull PI cattle if they want to 
regain normal cost-effective management possibilities for their livestock, by implementing 
serological testing for herd status in the programme. By linking the results to movement 
restrictions, a herd with a PI animal will be kept under restrictions as long as that animal is 
present. 
The third element of systematic BVDV control is monitoring. Early introduction of young 
stock serology tests, additional to continued ear notch testing of newborns, is a potential 
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solution to achieve a short eradication period, in spite of only newborns being virologically 
tested. Through the information campaign veterinarians must be trained in sampling for 
representative serological young stock tests. In a later phase surveillance of dairy farms can 
be executed through bulk milk serology. Evidently, efforts to detect infected herds will be 
rendered useless if not combined with cattle movement restrictions for infected herds and 
obligatory screening for PI animals in these herds. These measures must be implemented as 
soon as possible. 
Mandatory testing of all purchased cattle 
The Belgian identification and registration system, Sanitel, has proven to be an efficient 
basis for disease control and eradication. Nevertheless, the question arises whether the 
records are always correct at input. For example, it is known that registered mother-calf 
relationships do not always conform to reality (Denis Volckaert, personal communication). 
As according to the Belgian plan dams of calves registered BVDV-free will receive the 
“BVDV-free by progeny” status, an incorrectly registered dam-calf relationship might cause 
a PI dam to be missed. For that reason, if testing at purchase is not mandatory, the 
accompanying certificate must state clearly that the “BVDV-free by progeny” status has been 
obtained by relationship, and that the purchased animal itself has not been tested. Although 
the risk of a positive result is minimal, farmers must be informed that when purchasing a 
certified cow or heifer, it is safer to voluntarily test the animal for BVDV viraemia. Still, 
mandatory testing of all newly purchased cattle would be safer than admission based on 
certification.  
In Belgium, a BVDV test at purchase will not increase the costs substantially, as it can be 
combined with the current obligatory tuberculosis test of all cattle when moving from one 
herd to another. An additional advantage of testing at purchase is that all cattle imported from 
other countries are automatically tested for BVDV viraemia. Imported livestock must be 
BVDV tested anyway, if not the eradication period will inevitably be prolonged.  
In the Belgian control plan, as it is conceived now, the PI calf of a “Trojan cow” will be 
detected at birth through ear notch sampling. This however, does not take into account the 
risk of virus spreading by a so called Trojan cow giving birth to a PI calf. Farmers should be 
informed that strict quarantine is necessary to tackle that risk. The risk of the calving Trojan 
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cow also further strengthens the argument for regular serological testing to detect 
unsuspected re-infections. 
Certification at the animal level 
The Belgian plan is based on BVDV status at the animal level. This is a safe way of 
certifying. In contrast, prudence is called when providing BVDV status to herds, if that is the 
intention. If a herd status is assigned when all animals of the herd have been virologically 
tested and all are negative, then it can be concluded that there are no PI animals present. 
Nevertheless, BVDV can still emerge in the herd at any moment by direct or indirect 
contacts. Such an infection may give rise to a PI calf if cattle in the first months of pregnancy 
are involved. Furthermore, a BVDV-free status partially based on bulk milk testing through 
RT-PCR is unreliable, because farmers generally do not know exactly which cows delivered 
milk at the day of testing. In contrast to virus tests of newborns only, serological testing is 
capable to point out a transient BVDV infection. Nevertheless, if it is the intention to declare 
a herd BVDV free on one occasion, all animals have to be tested, both for virus and 
antibodies. As this option is not realistic, the alternative is continuous and regular serological 
testing of small groups of young stock.  
Herd statuses must be assigned early to detect surviving PI cattle and to be able to report 
on progress of the programme. In contrast, individual BVDV-free certificates for trade based 
on herd status must not be assigned to herds before PI prevalence has dropped substantially, 
in a later phase of the programme. If a farmer happened to buy a pregnant heifer from a 
“BVDV-free” herd that has been transiently infected during the first 125 days of pregnancy, 
confidence in the programme will be lost, and as a result also the compliance. Rumours of 
such a negative experience circulate easily among stakeholders and can irreversibly damage 
the programme. Hence, allocating BVDV-free status to individual animals based on herd 
status must be postponed until BVDV prevalence is very low. 
Conclusion  
The Belgian BVDV control programme must, as soon as possible, evolve to the 
systematic approach to obtain an acceptably short eradication period. Some key objectives 
such as efficient biosecurity cannot be reached through imposing rules. Therefore, and also to 
compensate for weaknesses in regulations, it is highly important for the Belgian BVDV 
control programme that a well elaborated information campaign is coupled with a restricted 
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number of clear rules. Implementing the following rules can make the Belgian programme 
more systematic:  
 Examining ear tissue through RT-PCR; 
 Imposing movement restrictions for the herd if a PI animal is present (preferably 
from the start of the programme); 
 Obligatory BVDV testing at purchase (to coincide with current obligatory tests); 
 Implementing serological monitoring as soon as possible; 
 Certification at the animal level, based on individual testing; postponing of 
individual certification based on herd status until the BVDV prevalence is low.  
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The pathogenesis of BVD is complicated. As a result, the disease can manifest itself 
through a variety of clinical presentations. This also makes a clinical diagnosis difficult or 
even impossible and often BVDV is not recognised as the cause of health problems in cattle. 
Despite numerous voluntary initiatives since more than 50 years, BVDV prevalence did not 
decrease, except for countries where an obligatory regional or national control programme 
has been imposed. Even the availability of BVDV vaccines with continuously increasing 
efficiency did not result in lower prevalence. 
In Belgium as well, information campaigns and voluntary BVDV programmes organised 
by the Animal Health Services have not been able to obtain progress: BVDV prevalence 
remains high. Hence, it was the objective of this doctoral thesis to demonstrate that unusual 
clinical presentations of BVDV infection are among the reasons why BVDV infection is 
difficult to detect through clinical diagnosis. Another objective was to examine if voluntary 
BVDV control in Belgium is executed following the guidelines recommended in scientific 
literature. Starting from the conclusions of these studies, an acceptable plan for BVDV 
eradication in Belgium is proposed.  
The general introduction (Chapter 1) consists of a literature review of knowledge on 
BVD, being relevant for this thesis. In the description of the pathogenesis of BVDV infection 
the key role of PI cattle is highlighted. Subsequently, the prevalence is presented, followed by 
a survey of the multiple clinical presentations of BVDV infection. In this section, the 
phenomenon of immunosuppression caused by BVDV is emphasized. With regard to BVD 
diagnosis, it is clear that due to the different clinical presentations, a diagnosis based on 
anamnesis, clinical presentation, and post mortem examination has to be considered 
provisional. For an accurate, conclusive diagnosis laboratory testing is required. In the final 
part of the general introduction, it is described how BVDV eradication in Belgium can be 
approached at the herd level following guidelines provided by the Animal Health Services 
and the Faculties of Veterinary Medicine.  
As field experiences reveal that not everyone is persuaded of the proposition that BVD 
cannot be recognised by its clinical manifestations, it was the intention to demonstrate in 
Chapters 3an 4 that exceptional clinical presentations and subclinical infection can partially 
explain why a clinical diagnosis of BVDV infection is difficult or impossible.  
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In a first case cp BVDV was detected in a 10-days-old calf during an outbreak of 
haemorrhagic neonatal diarrhoea. Since ncp BVDV had not been detected in the same 
animal, this was an extraordinary finding, also because of the young age of the calf. 
Moreover, the case pointed to the role of BVDV in co-infections.  
The two following case descriptions demonstrate that some clinical presentations do not 
immediately draw attention to BVDV as a potential cause. A 2-day-old calf showed 
spontaneous skin bleeding and thrombocytopenia (Chapter 3.2). This is a clinical 
presentation that is difficult to differentiate from those observed in calves suffering from 
BNP. The calf was shown to be PI with a BVDV1b strain. Other exceptional observations 
were the very young age of the calf as compared to calves suffering from BNP and the 
spontaneous recovery from HD, despite persistent BVDV infection. This result is an 
additional indication for the unpredictable clinical outcome of BVDV infection. In Chapter 
3.3 a cow is described suffering from haemorrhagic proctocolitis. Other cows of the herd had 
been seriously ill from haemorrhagic diarrhoea as well. Strikingly, no leucocytes could be 
detected in the blood of this cow transiently infected with BVDV1b. Retrospective 
investigation revealed that a 3-months-old calf was housed in close contact with the freshly 
calved cows at the time of the outbreak in these cows, and that the BVDV most likely had 
entered the herd via machinery commonly used with another farm. Both the calf and the cow 
described in Chapter 3.2 and 3.3 were infected with BVDV1b, the most prevalent BVDV 
subspecies in Belgium, although it is still generally accepted that BVDV2 is almost 
exclusively responsible for BVDV associated HD. 
Subsequently, potential subclinical damage caused by BVDV was studied (Chapter 4). A 
study on 406 Belgian dairy farms showed an association between the degree of BVDV 
infection of herds and the BMSCC, a proxy for subclinical mastitis. Herds considered 
BVDV-free had significantly lower BMSCC than herds where, according to BVDV-antibody 
OD ratios in bulk milk, active BVDV infection was still present, or where BVDV had 
circulated recently. This study revealed as well that only 11.3% of the 241 herds involved 
could be considered BVDV-free at the moment of sampling. 
It is evident that laboratory testing is indispensable when a disease, such as BVD, is not 
recognisable through clinical diagnosis. Tests are necessary both for diagnosis of BVD in 
individual animals and for surveillance. Continuous monitoring is used to detect BVDV 
infection of herds and to alert in time for re-infection.  
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It is generally accepted that three elements are essential to efficient BVDV control: 
biosecurity measures, detection and removal of PI animals, and monitoring. A BVDV control 
programme containing these three elements is called “systematic”. 
To examine why also in Belgium the prevalence of BVDV remains high, the voluntary 
attempts to BVDV control in Flanders have been studied in Chapter 5. The results showed 
that BVDV control is inefficient in most herds. In a majority of herds (63%) the BVDV status 
was unknown, since continuous monitoring was not implemented in the approach. Moreover, 
in 71% of herds cattle were vaccinated against BVDV without previous knowledge of the 
BVDV status, thus without previous detection and removal of PI cattle. Hence, two essential 
pillars of BVDV control, elimination of PI animals and monitoring were lacking on most 
farms.  
Experiences from the past learn that BVDV control programmes only can succeed if they 
are systematic in the first place, and secondly, if conducted at the regional or national level. 
The logical conclusion is that the correct way to an efficient BVDV control for Belgium is a 
national, mandatory programme. In the final part of the discussion of this thesis requirements 
are adduced for eradication over an acceptably short period. Hereby compliance by 
stakeholders and practical as well as financial feasibility have been taken into account.  
The strategy of the Belgian plan, as designed actually, consists of mandatory testing of all 
newborn calves during several years. The ear notch method will be the test of choice. 
In the first phases the programme will not be systematic, since it is the intention to test 
only newborns and neither immediate removal of PI animals, nor measures for farms housing 
PI cattle will be imposed. Therefore, the time period until continuous interruption of 
transmission of the virus might be prolonged. This can be an acceptable strategy, because 
starting with a simple control plan is an appropriate way to obtain compliance of the 
stakeholders. Still, additional rules have to be implemented as soon as possible in the 
following phases. If not the eradication period will become too long. As a result, the 
compliance of farmers and veterinarians might languish. Moreover, not testing all cattle at 
purchase is a weak point of the Belgian plan, because purchase is a key route for BVDV 
infection to enter herds. Adding a mandatory test at purchase undoubtedly would be an 
improvement, as it also would implement testing of all imported cattle. 
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The intention is to start with a limited programme, easy to explain and to execute. 
Following regular evaluations of the progress made, the rules will be changed gradually into 
a more stringent regulation. On the one hand constraints can be suspended for farms where 
BVDV eradication has been achieved, on the other hand, more strict rules can be 
implemented for the remaining herds. In anticipation of more stringent regulations, a well 
managed information campaign is the tool of choice to overcome the shortcomings of the 
initial phases. As an example, the importance of biosecurity can be highlighted and 
biosecurity measures can be taught via the campaign, or farmers can be advised that a test for 
BVDV infection at purchasing cattle remains safer than certification. The economic 
consequences of BVDV infection can also be explained and recalled repeatedly.  
In the Belgian programme BVDV certificates will be based on individual testing. Such a 
certificate offers more security to a buyer of cattle than a certificate based on herd status. An 
animal certified PI free remains lifelong PI free. In contrast, a herd certified BVDV-free 
today, can become re-infected tomorrow. Therefore, it is advisable to postpone individual 
certification based on herd status until BVDV prevalence in Belgium has decreased to a very 
low level, and, as a result, the risk of re-infection of herds has become low. Nevertheless, 
monitoring has to be implemented as soon as possible, not for certifying, but to detect herds 
housing PI cattle and to be able to evaluate the progress made. 
In conclusion, the Belgian BVDV eradication programme can only succeed if two 
preconditions are fulfilled. Firstly, a well organised information campaign has to be part of 
the programme and secondly, rules must be made more stringent as soon as possible. In that 
way a systematic eradication programme can be achieved and finalised within an acceptable 
period of time.  
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De pathogenese van BVD is ingewikkeld. Als gevolg daarvan kan de ziekte zich 
manifesteren onder een veelvoud aan klinische verschijningsvormen. Daarom is ook de 
klinische diagnose moeilijk tot dikwijls onmogelijk, waardoor men bij 
gezondheidsproblemen op rundveebedrijven vaak niet beseft dat BVDV de oorzaak is. 
Ondanks de vele initiatieven tot vrijwillige eradicatie sinds meer dan 50 jaar, is er wereldwijd 
geen daling van de prevalentie vastgesteld, behalve in landen waar er een verplichte regionale 
of nationale controle werd opgelegd. Ook het ter beschikking komen van steeds betere 
vaccins tegen BVDV heeft geen daling van de prevalentie opgeleverd.  
Informatiecampagnes en vrijwillige BVDV-programma’s van de Dierengezondheids-
diensten hebben ook in België geen vooruitgang kunnen teweegbrengen: de BVDV-
prevalentie blijft hoog. Het was dan ook een van de doelstellingen van deze doctoraatsthesis 
om aan te tonen dat de klinische diagnose van BVDV-infectie moeilijk is, onder andere door 
uitzonderlijke klinische verschijningsvormen en subklinische besmettingen. Daarnaast werd 
ook nagegaan of in Vlaanderen de vrijwillige BVDV controle wel uitgevoerd wordt volgens 
de door de wetenschappelijke literatuur aanbevolen richtlijnen. Gebruik makend van de 
verkregen resultaten wordt er een aanvaardbaar plan voor een efficiënte BVDV-eradicatie in 
Belgïe voorgesteld. 
De algemene inleiding (Hoofdstuk 1) bestaat uit een literatuuroverzicht waarin kennis 
over de ziekte BVD is opgenomen, die ook relevant is voor de verdere inhoud van de thesis. 
In de beschrijving van de pathogenese van BVD wordt de belangrijke rol van persisterend 
geïnfecteerde runderen benadrukt. Na de bespreking van de prevalentie wordt de diversiteit 
van de klinische verschijningsvormen aan de orde gesteld. Daarbij wordt het fenomeen van 
immunosuppressie bij transiënte BVDV-besmetting benadrukt. Vervolgens wordt er 
aangegeven dat de schade die BVDV op een bedrijf aanricht moeilijk te meten is en daardoor 
wellicht onderschat wordt. Toch weet men dat de grootste schade wordt veroorzaakt door 
reproductiestoornissen en immunosuppressie, waardoor andere infecties gemakkelijker 
aanslaan en ernstige klinische gevolgen kunnen hebben. Als het op het stellen van de 
diagnose aankomt, dan blijkt dat het aantonen van een BVDV-infectie op basis van 
anamnese, klinisch beeld en lijkschouwing alleen maar als indicatief kan beschouwd worden. 
Voor een accurate en definitieve diagnose zijn laboratoriumtesten noodzakelijk. In het laatste 
deel van de algemene inleiding wordt uitgelegd hoe eradicatie op bedrijfsniveau in België 
Samenvatting  
 
174 
 
praktisch kan aangepakt worden volgens de richtlijnen van de dierengezondheidsdiensten en 
de faculteiten diergeneeskunde. 
Omdat uit praktijkervaringen blijkt dat niet iedereen ervan overtuigd is dat BVD moeilijk 
tot niet te herkennen is aan de hand van het klinisch beeld, wordt in Hoofdstuk 3 aangetoond 
dat uitzonderlijke klinische verschijningsvormen kunnen verantwoordelijk zijn voor de 
moeilijke klinische herkenbaarheid van BVD. 
Bij een eerste casus werd er cytopathogeen (cp) BVDV ontdekt bij een 10 dagen oud kalf 
gedurende een uitbraak van bloederige neonatale diarree. Omdat er geen cytopathogeen (ncp) 
virus op hetzelfde ogenblik werd aangetroffen, was dat een uitzonderlijke bevinding, zeker 
als ook de jonge leeftijd van het kalf in acht wordt genomen. Uit de twee volgende 
casusbeschrijvingen blijkt dat er klinische beelden bestaan die niet meteen aan BVD doen 
denken. Zo vertoonde een twee dagen oud kalf spontane huidbloedingen en 
thrombocytopenie. Dit zijn verschijnselen die klinisch moeilijk te onderscheiden zijn van de 
ziektetekens waargenomen bij kalveren lijdend aan Boviene Neonatale Pancytopenie (BNP) 
(Hoofdstuk 3.2). Het kalf was persisterend geïnfecteerd (PI) met een BVDV1b stam. 
Uitzonderlijk waren het spontane herstel van het hemorragisch syndroom bij dit PI kalf en de 
jonge leeftijd in vergelijking met de leeftijd van BNP kalveren. Deze bevinding wijst 
opnieuw naar de onvoorspelbare klinische verschijnselen van BVDV-besmetting. In 
Hoofdstuk 3.3 wordt een koe besproken die ernstig algemeen ziek was kort na de partus en 
bloederige proctocolitis vertoonde. Andere koeien van het bedrijf waren daarvoor ook ernstig 
ziek geweest met bloederige diarree als het meest opvallende ziekteteken. Opvallend bij deze 
casus was het totaal ontbreken van leucocyten bij bloedanalyse van de betreffende koe die 
transiënt besmet was met BVDV1b. Bij retrospectief onderzoek bleek dat gedurende de 
uitbraak een drie maanden oud PI kalf naast de pasgekalfde koeien gehuisvest was geweest. 
Dit kalf had de koeien besmet met BVDV. Het virus was hoogstwaarschijnlijk het bedrijf 
binnengekomen via materiaal dat gemeenschappelijk gebruikt werd met een ander bedrijf. 
Het valt op dat het kalf en de koe beschreven in de hoofdstukken 3.2 en 3.3. besmet waren 
met BVDV1b, de bij ons meest gevonden BVDV subspecies, terwijl nog steeds algemeen 
aangenomen wordt dat bijna uitsluitend BVDV2 verantwoordelijk is voor het hemorragisch 
syndroom (HD).  
Vervolgens werd gezocht naar tekenen van mogelijke subklinische schade door BVDV. 
Uit een onderzoek op 243 Vlaamse bedrijven waar niet gevaccineerd werd tegen BVDV, 
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bleek dat er een relatie is tussen de graad van BVDV-besmetting van een bedrijf en het 
tankmelkcelgetal (Hoofdstuk 4). BVDV-vrije bedrijven hadden een significant lager 
tankmelkcelgetal dan bedrijven waar er volgens de BVDV-antistoffentiter in de tankmelk nog 
actieve BVDV-infectie mogelijk was of waar er kort voor het onderzoek nog infectie geweest 
was. In deze studie viel het ook op dat slechts 11.3% van de 243 onderzochte 
melkveebedrijven als BVDV-vrij kon beschouwd worden op het ogenblik dat de stalen 
werden genomen.  
De drie casusbeschrijvingen uit deze thesis zijn een aanvullend bewijs van de stelling dat 
het klinisch beeld van BVD erg kan variëren naargelang de virulentie van de BVDV-stam, de 
immuniteitsstatus en de leeftijd van de gastheer en bijkomende infecties met andere 
pathogenen. 
 Het is evident dat er voor het detecteren van een ziekte zoals BVD die vaak niet kan 
gedetecteerd worden via een klinische diagnose, gebruik moet gemaakt worden van 
laboratoriumtesten. Deze testen zijn zowel nodig voor het stellen van de diagnose bij 
individuele zieke dieren, als voor het voortdurend monitoren van rundveebedrijven. Dit 
monitoren is zowel voor het ontdekken van BVDV-circulatie op bedrijven, als voor het tijdig 
opmerken van eventuele herinfectie na eradicatie noodzakelijk.  
Algemeen wordt aangenomen dat er voor een efficiënte BVDV controle drie elementen 
onontbeerlijk zijn: bioveiligheidsmaatregelen, detectie en verwijdering van alle persisterend 
geïnfecteerde (PI) runderen en het nauwkeurig opvolgen van de situatie (monitoren). Een 
BVDV-bestrijdingsprogramma dat deze drie onderdelen omvat noemt men “systematisch”.  
Om na te gaan waarom in Vlaanderen de controle van BVDV niet blijkt te lukken, werd 
in Hoofdstuk 5 onderzocht of de vrijwillige pogingen tot BVDV-bestrijding wel voldoende 
systematisch worden uitgevoerd. Uit de verkregen gegevens blijkt dat de BVDV-bestrijding 
in Vlaanderen op de meeste rundveebedrijven inefficiënt verloopt. De meeste bedrijven 
(63%) kenden hun BVDV-status niet, omdat monitoren niet plaats vond. Ook werd er op 71% 
van de bedrijven gevaccineerd tegen BVDV zonder voorkennis van de BVDV-status van het 
bedrijf en dus zonder het voorafgaand opsporen en verwijderen van PI runderen. Dit betekent 
dat twee van de drie vereiste peilers van een efficiënte BVDV-bestrijding, met name het 
verwijderen van PI dieren en het monitoren, op de meeste bedrijven ontbreken.  
Samenvatting  
 
176 
 
Het onderzoek naar het BVDV-management op Vlaamse melkveebedrijven (Hoofdstuk 5) 
toont aan dat, net zoals dit in andere landen het geval is, de vrijwillige aanpak op 
bedrijfsniveau niet werkt voor BVD. 
Ervaringen uit het verleden leren dat alleen die eradicatieprogramma’s slagen die én 
systematisch waren én op het regionaal of nationaal niveau gevoerd werden. Hieruit volgt 
logisch dat de enige juiste weg naar een afdoend BVDV-eradicatieprogramma in België dient 
te bestaan uit een nationaal verplicht programma.  
In het laatste deel van dit proefschrift worden een aantal voorwaarden aangegeven 
waaraan een toekomstig Belgisch nationaal BVDV-programma moet voldoen om te slagen in 
een voldoende snelle eradicatie. Daarbij is rekening gehouden met de praktische 
haalbaarheid, de financiële mogelijkheden en de kans op aanvaarding door de betrokkenen. 
De strategie van het Belgische programma zoals het nu voorligt bestaat uit het verplicht 
testen van alle pasgeboren kalveren gedurende meerdere jaren. Daarvoor zal de “ear notch” 
test gebruikt worden.  
Omdat er in de eerste stadia van het Belgische programma alleen pasgeboren kalveren 
zullen worden getest, de afvoer van PI runderen niet zal worden verplicht en er geen 
maatregelen opgelegd zullen worden aan bedrijven waar een PI dier ontdekt werd, zal het 
programma aanvankelijk niet systematisch zijn en kan de periode tot stopzetting van 
transmissie van BVDV verlengd worden. Dit kan een aanvaardbare strategie zijn, omdat 
starten met een eenvoudig bestrijdingsplan aangewezen is om zich van de medewerking van 
de veehouders te verzekeren. Toch moeten er bij de volgende stappen zo spoedig mogelijk 
een aantal regels toegevoegd worden, zo niet zal de eradicatieperiode veel te lang duren. Dit 
zou dan op zijn beurt de interesse van veehouders en dierenartsen nadelig beïnvloeden. 
Daarnaast is het niet testen van alle aangekochte runderen een duidelijk zwak punt van het 
Belgische plan, want het aankopen van runderen is een van de belangrijkste oorzaken van 
overdracht van BVDV tussen bedrijven. Het toevoegen van een verplichte BVDV 
aankooptest zou een verbetering zijn, des te meer omdat door deze maatregel meteen ook alle 
ingevoerde runderen automatisch mee getest worden.  
Het is de bedoeling om te starten met een beperkt programma dat goed is uit te leggen en 
uit te voeren. Daaropvolgend wil men, na het evalueren van de vooruitgang, steeds weer een 
volgende stap toevoegen, waarin enerzijds verplichtingen kunnen wegvallen voor bedrijven 
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die al ver gevorderd zijn met de bestrijding, maar waarin anderzijds strengere maatregelen 
kunnen opgenomen worden voor de overige bedrijven. In afwachting van een meer stringent 
reglement, is een goed gevoerde informatiecampagne het aangewezen middel om de 
zwakheden in de eerste fase van het programma op te vangen. Daarin kan men er de 
veehouders bijvoorbeeld op wijzen dat testen bij aankoop toch nog altijd veiliger is dan 
certificatie. Deze informatiecampagne is niet alleen nodig voor het opvangen van 
tekortkomingen in het programma, maar er kan bovendien gewezen worden op het grote 
belang van bioveiligheid. De economische gevolgen van BVDV-infectie moeten al voor de 
start uitgelegd en steeds opnieuw benadrukt worden.  
Het Belgische programma zal met individuele BVDV certificaten werken. Dit geeft meer 
zekerheid voor een eventuele koper van een rund dan bedrijfscertificatie. Een rund dat PI-vrij 
is en ook zo gecertificeerd wordt, blijft levenslang PI-vrij, maar een bedrijf dat vandaag 
BVDV-vrij verklaard wordt, kan morgen opnieuw besmet worden. Daarom is het aan te 
bevelen om te wachten met individuele certificatie op basis van vrijverklaring van het bedrijf, 
tot de prevalentie in België zeer laag is geworden en daarmee ook het risico op herinfectie 
van bedrijven. Dat neemt niet weg dat monitoring zo spoedig mogelijk moet ingevoerd 
worden, maar niet om te certifiëren. Via monitoren moet de BVDV-status van bedrijven in 
kaart gebracht worden. Deze kennis is belangrijk om de mogelijke aanwezigheid van PI 
runderen te ontdekken en om de vooruitgang van het programma te evalueren. Dit laatste is 
nodig om gefundeerd verdere stappen te kunnen nemen en om verzekerd te blijven van de 
medewerking van veehouders. 
Het komt er op neer dat het Belgische BVDV-eradicatieprogramma alleen kans van 
slagen heeft als het gecombineerd wordt met een degelijke informatiecampagne en als de 
efficiëntie van het programma zo spoedig mogelijk wordt aangescherpt met bijkomende 
verplichtingen en beperkingen. Aldus kan men ondanks de eenvoudige aanpak in de 
beginfase, toch komen tot een systematisch eradicatieprogramma dat binnen een redelijke 
termijn kan afgewerkt worden. 
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Dit dankwoord zal er zeker geen zijn zoals men dat gewoonlijk kan lezen bij jonge 
doctorandi. Ik wil absoluut vermijden dat ik iemand zou vergeten, wanneer ik iedereen 
probeer te noemen aan wie ik op één of andere manier steun heb gehad, gedurende die bijna 
14 jaar op de Faculteit. Van sommigen heb ik heel veel geleerd, anderen waren voorbeelden 
op persoonlijk of op professioneel vlak. We werkten goed samen, of konden onze ideeën 
uitwisselen. Met sommige collega’s konden we dikwijls samen lachen. Dat schept een band, 
waardoor we soms vrienden zijn geworden worden. De studenten en de interns mag ik zeker 
niet vergeten, want zij hebben mij jong van geest gehouden, waardoor ik me bijvoorbeeld nog 
zo gek liet maken om mij nog de stress van een doctoraat op de hals te halen. Na dit werk 
moet ik opnieuw met de studenten de buitenpraktijk in. 
Sta me toe dat ik dus alleen de namen noem van wie rechtstreeks met dit doctoraatswerk 
te maken heeft gehad. Mocht ik in dat verband toch nog iemand vergeten zijn, vergeef het 
me. Schrijf het toe aan de drukte van deze eindfase, en zoek er verder niets achter. 
Eerst wil ik professor de Kruif bedanken, omdat hij mij altijd de vrijheid geboden heeft 
om me verder te ontwikkelen, terwijl ik toch was aangenomen als praktijkassistent. Een 
BVD-vraag die hij had ontvangen vanuit Nederland en waarmee hij naar mij toe kwam om 
mijn mening te kennen, was uiteindelijk de aanzet tot het overzichtsartikel in de Veterinary 
Journal.  
Professor Sarne De Vliegher heeft toch wel duidelijk de taak van eerste promotor 
opgenomen. Hij heeft in de eindfase zowel het schrijven van dit werk als het maken van de 
presentatie begeleid. Hij benadrukte meermaals dat ik hem op elk moment teksten mocht 
voorleggen. Bovendien nam hij me mee naar het symposium in Toronto, waar hij me opdroeg 
om iets te vertellen over BVD en mastitis. Daarmee legde hij de basis voor het 
onderzoeksartikel over celgetal en BVDV-infectie.  
Ook bij professor Jeroen Dewulf kon ik altijd terecht wanneer ik eens vast zat. Hij nam 
me ook mee naar Leipzig, waar ik mijn “BVD-goeroe”, Ann Lindberg, nog een keer kon 
ontmoeten. Wanneer ik aan Jeroen een artikel gaf om het door te lezen, vond ik zijn oordeel 
altijd veel te streng, maar achteraf had ik er voordeel bij.  
Professor Geert Opsomer was diegene die me er op attent heeft gemaakt dat ik wel de 
geschikte man was om in de buitenpraktijk te komen werken. Hij zette me dan ook nog de 
eerste week al aan het schrijven, toen nog over Neospora, maar dat schrijven beviel me wel. 
Hij werd pas later bij dit doctoraat betrokken als derde promotor, maar met korte 
tussenkomsten kon hij me soms heel snel de goede richting aanwijzen waarin ik verder 
moest.  
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Toch moet ik de promotoren bekennen dat ik nooit aan een doctoraatswerk zou begonnen 
zijn, mocht professor Deprez me er niet toe hebben aangespoord. Toen hij zei “Maak eens 
een doctoraat van uw BVD-kennis”, was dat voor mij een van de redenen om er aan te 
beginnen. Het was een geweldige stimulans om voortdurend begeleid te worden door de 
wijze raad van iemand naar wie ik altijd zo heb opgekeken. Hij heeft me gedurende al die tijd 
bijgestaan met zijn uitgebreide kennis, inzicht en wijsheid, en dat altijd in zijn bekende, 
bescheiden stijl.  
In een adem met professor Deprez moet ik ook Bart Pardon vernoemen. Samen hebben 
wij vele BVD-avonturen beleefd en veel BVD besproken. Ook bij hem kon ik altijd met mijn 
vragen terecht. Net als professor Deprez speelde hij het, als jonge gast, ook nog klaar om die 
ouwe van de buitenpraktijk moreel te ondersteunen. Vakgroepen van onze Faculteit zouden 
meer moeten samenwerken zoals wij dat hebben gedaan en - laat ons hopen - nog veel zullen 
doen.  
Ook de andere leden van de begeleidingscommissie ben ik dankbaar. De tussenkomsten 
van professor Nauwynck waren beperkt in aantal, maar toch zo nuttig. Hij vond onder andere 
meteen een oplossing voor het lastige probleem van de plaatsing van het overzichtsartikel. 
Van de bijdrage van Dr. Ann Brigitte Caij onthoud ik vooral de zeer nuttige bespreking op 
het CODA met haar en Miet (De Baere). Miet moet ik ook nog bedanken voor de vele 
vraagjes die ze nog heeft beantwoord in de laatste dagen van afwerking van de thesis. 
Dear Professor Lindbergh, when we met at the BVD-day in Munich and I invited you to 
be a member of the examination commission, you made me so happy by accepting 
immediately. Having the worlds’ most famous specialist in BVDV control in the commission, 
is an immense honour to me. There are more BVDV icons, but in control of BVDV, you are 
excelling. That is why I use to call you “my BVDV guru”. 
Dear Richard, the day the promoters agreed to admit a second commission member from 
abroad, I went home in a very good mood. I learned a lot from your own research on BVDV 
and always appreciated your valuable comments on my articles. Moreover, being an 
Anglophile, I am happy to have a genuine Englishman in the commission.  
Beste Axel, vanaf de eerste vergadering met jou erbij, enkele jaren geleden, viel mij 
meteen op dat jij naast een grote kennis ook een scherp inzicht bezit. Daarom wou ik je ook 
graag in de commissie voor dit doctoraat. Het was ook aangenaam om te kunnen over BVDV 
discussiëren met iemand van Luik. Wij wisselen allemaal kennis uit met collega’s van allerlei 
landen, maar veel te weinig met onze zuster-Faculteit in eigen land.  
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Beste Stefaan, jij mocht zeker ook niet ontbreken. Wij hebben nog samen aan het 
overzichtartikel voor de Veterinary Journal gewerkt en jij bent stilaan “mijnheer BVD” aan 
het worden in Vlaanderen en in heel België. Inderdaad, bij de vergaderingen van de BVD-
werkgroep merk ik meer en meer dat men bij de discussies niet om je heen kan.  
Sofie, met wie ik de werkkamer deel, ben ik ook zeer dankbaar. Zij heeft de statistiek van 
het onderzoeksartikel aangepakt en terwijl ik aan het schrijven was kon ik bij haar terecht 
voor zowat alles, van wetenschappelijke vragen tot taal- en computerweetjes. Ook alle andere 
collega’s die mij hebben geholpen om technische probleempjes op te lossen wil ik hier 
bedanken, samen met het technisch personeel. Zij hebben dikwijls de stress wat weggenomen 
door vele kleine tussenkomsten. Dat ging van adressen opzoeken, over computer-
probleempjes oplossen, tot administratieve zaken regelen.  
Sommige collega’s mailden me de BVD-artikels door die zij op hun zoektocht naar meer 
kennis gevonden hadden, waarvoor ik hen zeer dankbaar ben. 
Dank ook aan die dierenartsen van de buitenpraktijk die het me hebben gegund om een 
doctoraatswerk aan te pakken en die me daarom wat meer aan mijn bureau lieten werken. 
Het was aangenaam werken met de co-auteurs van de wetenschappelijke artikels voor dit 
werk: Carine Letellier, Vanessa Meganck, Jean-Marie Van Crombrugge, Stefaan Ribbens, 
Steven Sarrazin, Dirk Pfeiffer en de anderen die ik al heb vermeld in dit dankwoord. Toen 
Stefaan naar DGZ was vertrokken, was ik een tijdje alleen als BVD-man bij de 
buitenpraktijk, maar al spoedig was daar Steven om het lijstje van BVD-brainstormers aan 
onze vakgroep aan te vullen, na Geert Vanroose, Geert Hoflack en Stefaan (allemaal mannen; 
wanneer komt er eens een BVD-vrouw?). 
Dank aan alle veehouders die meewerkten aan de enquêtes. Toen ik hen belde legden 
sommigen zelfs hun tractor stil op het veld of ze belden zelf terug als ze een gemiste oproep 
hadden opgemerkt. 
Dajo en Anne hebben me voortreffelijk geholpen voor de figuren en de omslag van de 
thesis. 
Thank you Keith, Richard, Neil, Bruno, Wim and Jan for checking the language of the 
articles or the thesis.  
Dank ook aan alle BVD-freaks in binnen- en buitenland, practici, wetenschappers, 
dierenartsen uit de industrie en labo-medewerkers met wie ik over dit interessante virus en 
zijn daden vele discussies heb mogen voeren.  
Omdat ik geen enkel budget ter beschikking had voor dit werk en het voor de vakgroep 
crisis is, net als voor iedereen, acht ik me gelukkig dat vier sponsors zich meteen bereid 
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verklaarden om de kosten voor het drukwerk te betalen. Dank daarvoor aan Idexx, 
Boehringer, MSD, en Zoetis. 
Hedwige heeft me op het hart gedrukt dat ik haar hier niet moest vermelden, want ik had 
me voorgenomen om alleen diegenen te vernoemen die rechtstreeks te maken hebben met dit 
werk. Maar als er iemand is die er mee te maken heeft gehad is zij het wel. Sinds juni 2013 
heb ik thuis geen klap meer uitgevoerd (Vanaf komend weekend ga ik weer aan de slag in de 
tuin en met karweien in het huis!). Hedwige heeft altijd zonder enig morren aanvaard dat ik 
me terugtrok om verder te werken aan dit doctoraat. Daarom staat ze ook vermeld vooraan in 
het boekje, naast mijn moeder. 
Griet en Jan hebben er ook mee te maken. Als ik het soms eens niet zo goed zag zitten, 
dan dacht ik meteen: zij plooien ook niet en staan wel eens meer voor een zware taak. Het is 
enig wanneer je als vader een voorbeeld kan nemen aan je kinderen. Ik beloof jullie dat jullie 
ma en ik zullen blijven  
 
rage, rage, against the dying of the light. 
 
Jef 
 
 
 
 
 
 
 
 
 
 
 
 
 

